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CHAPTER 1
INTRODUCTION AND BACKGROUND
1.1 Cancer/Acanthosis Nigricans
Cancer and diabetes are common chronic diseases in the world causing numerous
deaths in adults as well as children.

Cancer can occur in various organs of adults and

children. Some of the common types of cancers in adults are prostate, breast, colon, head
and

neck

squamous

cell

carcinoma,

ganglioneuroma are quite common.

while

among

children;

neuroblastoma

and

In 2008, 903,500 (14%) new prostate cases were

recorded and about 258,400 (6%) men died. The highest incidence rates are observed in
the developed countries such as Oceania, Europe, and North America. 1

There are 25.8

million (8.3% of US population) children and adults in America who suffer from diabetes and
nearly 7 million people are not aware of their diabetic condition. 2 If untreated, many long
term health problems such as kidney failures, blindness, neuropathies, risk of heart
diseases, stroke and complications in pregnancy can happen.
What is common to both these illnesses is the necessity to detect these conditions in
their early stages so that appropriate medical treatments can be provided to avoid
complications in their later stages and possibly prevent deaths. Most common early cancer
detection techniques include screening tests such as mammography, cytology, prostate
specific antigen (PSA), trans-rectal ultrasound tests, Pap exams, biopsies, and blood tests.
In addition, imaging tests such as CT, MRIs, and nuclear medical scans are also used
widely.
Most of the above diagnostic procedures are lengthy and expensive.

With the

advancement in optical technologies, it is becoming desirable to have non-invasive and
reliable optical detection methods whose results are interpreted objectively.

Raman

spectroscopy and diffuse reflectance spectroscopy are two of the widely used analytical
optical spectroscopic methods where the spectral output contains information about the

2

molecular composition of the target tissue. For example, Raman spectroscopy can measure
changes in the bio-molecular composition of a tissue.

At the onset of the disease in an

organ, the biochemical composition begins to change from its normal values.
Diffuse reflectance spectroscopy provides direct measurement of light absorption and
scattering from a medium.

For example, diffuse reflectance spectrum can provide

information about the main chromophores (light absorbing chemical groups) present in skin
(hemoglobin and melanin) and other optical properties such as scattering coefficients and
scatterer size. 3
The main goal of our research work is to investigate the applications of (1) Raman
spectroscopy to diagnose head and neck squamous cell carcinoma, prostate cancer, and
pediatric tumors, and (2) diffuse reflectance spectroscopy to detect acanthosis nigiricans
skin disorder. The optical spectroscopic methods can possibly detect the onset of a disease
which otherwise can be elusive to conventional methods of detection or to the person
suffering from it.

1.1.1 Head and Neck Squamous Cell Carcinoma
The most common malignancy in the head and neck region is the head and neck
squamous cell carcinoma.

Worldwide, 644,000 new cases are diagnosed every year, of

which about 49,260 cases are reported in the United States, resulting in 16,320 deaths
every year. 4

The main tumor sites are oral cavity (tongue, lip or floor of mouth), nasal

cavity, paranasal sinuses, salivary glands, pharynx (nasopharynx, oropharynx, and
hypopharynx), larynx, trachea, and esophagus (see Fig. 1.1). The use of tobacco including
smokeless tobacco products is the major cause for all of the head and neck cancers. The
risk of developing squamous cell carcinoma in oral cavity is higher for the people who are
habitual smokers, alcohol consumers, and betel quid chewers. 5

3

Figure 1.1 Tumor sites for head and neck cancers 6

Carcinoma in situ is the precursor lesion of the head and neck squamous cell
carcinoma.

Squamous dysplasia, an abnormality of the squamous epithelium is also

considered as the precursor to invasive squamous cell carcinoma. However, it is difficult to
separate squamous dysplasia from carcinoma in situ as the morphological changes show a
continuum. The key pathological findings to distinguish between normal and carcinoma in
situ are architectural disorder, nuclear size variability, nuclear irregularity, and the nuclear
chromatin changes. 7 During the progression of carcinoma, downward growth, complex and
irregular branching, paradoxical keratinization, excessive volume of atypical epithelial
proliferation in the stroma, and inflammatory stromal response to the invading tumor can
happen. An example of epithelial cells invading the stroma can be seen from Fig. 1.2.

4

Squamous
cells

Stroma

Figure 1.2 Tongue squamous cell carcinoma: Invasion of epithelial cells into the stroma

Currently, the tumor-node-metastasis (TNM) staging is one of the most important
factors clinically used for estimation of survival. The clinical stages are listed in the Table
1.1. Reliable estimates of survival are important not only for patient counseling but it may
also impact the physicians’ choice of therapy. Physicians take into consideration the TNM
stage when recommending treatment options.

Early stage patients are offered single

modality treatment such as radiation or surgery, while multimodality treatment is offered
for advanced stage cancer.

Head and neck squamous cell carcinoma is a heterogeneous

disease and TNM staging provides only a rough estimation. 8

Not all patients in the same

tumor stage respond in a uniform manner to the available treatment options.

With the

availability of novel technologies, there is an urgent need to improve diagnostic accuracy,
prognosis, and treatment of head and neck squamous cell carcinoma patients.

Clinical stage

Description

0

Tis, N0, M0

I

T1, N0, M0

II

T2, N0, M0

III

T3, N0, M0/ T1-3, N1,M0

IV

T4, N0-1-M0/Any T, N2-3, M0/Any T, and N, M1
Table 1.1 A description of TNM clinical staging8

5

The nomenclatures of the Table 1.1 are; Tis: carcinoma in situ, T1: Tumor less than
2 cm in dimension, T2: Tumor size is between 2 cm and 4 cm, T4: Tumor invades adjacent
structures, N0: No regional lymph node metastases (M), N1: M to a single ipsilateral lymph
node (≤3 cm), N2: N1 but less than or equal 6 cm, M0: No evidence of distance M, and M1:
Distance M can be seen.

1.1.2. Prostate Cancer
Prostate cancer is one of the most common type of cancers among North American
men. The mortality rate for this disease can be dramatically reduced if it can be diagnosed
in its early stages with some reliable technique. Cancer occurs in the prostate gland which
is a part of the male reproductive system as shown in Fig. 1.3. It produces and stores an
alkaline fluid which provides an extra medium for mobility and life of sperm. The prostate
consists of three zones: peripheral zone, transition zone and central zone.

Figure 1.3 Prostate Gland 9

The peripheral zone is nearly 70% of the glandular mass of the prostate. Most of the
prostate cancers originate predominantly in this zone. The central zone is nearly 25% of
the prostate and rarely contributes to prostatic carcinoma. If the cancer develops from the
epithelial cells, it is referred to as “carcinoma”. However, it contributes to the spread of the

6

cancer since it is surrounded and accompanied by the ejaculatory ducts from the seminal
vessel. 10

The transition zone which is 5% of prostate volume is the origin of basal cell

hyperplasia, clear cell cribriform hyperplasia and clear cell carcinoma.

a) Prostatic Intraepithelial Neoplasia
Prostatic Intraepithelial Neoplasia (PIN) is a precursor lesion in prostate cancer which
can be of high grade or low grade category. Usually, PIN is classified as high grade capable
of developing into cancer within the next 10 years or so. 11 One study has suggested that
anti-tumor activity of certain dietary flavonoids prevents the progression of high grade PIN
to cancer. 12

However, this hypothesis could not be established in a randomized double-

blind study performed with 303 men in twelve Canadian centers. These men were given
soy, vitamin E, and selenium on daily basis for three years.

The results were not

statistically significant to show their effects on decreasing the progression of cancer or
eliminating it. 13

When the cancer progresses, the epithelium thickens due to the

development of atypical cells. In addition, intra-luminal papillae are formed as seen in Fig.
1.4 (b) and ultimately the glandular lumen will be linked creating a papillary arrangement.

(a)

(b)

Figure 1.4 (a) Low-grade PIN which has a star shaped glandular form with a prominent
basal layer (b) High-grade PIN shows increased number of atypical cells in the lining of the
duct

7

PIN is mainly seen in needle biopsies of benign prostatic hyperplasia (an
enlargement of prostate in men over 50) and in cancer patients as well. The patients who
have high grade PIN histology have high probability of developing prostate cancer.

b) Categorization of Cancer: The Gleason Grading System
Prostate cancer is categorized using the Gleason system which is used to evaluate
the prognosis of men with prostate cancer.

In this system, a tissue is assigned five grades

ranging from 1 to 5 to indicate the degree to which the cancerous tissue differs,
histologically, compared to normal prostate tissue.

Grade 1 is more towards the normal

prostate morphology which contains proliferated microacinar structures contoured by
prostatic luminal cells without a basal cell layer. 14

Grade 5 contains irregular, poorly

differentiated infiltrating individual cells, and grade 2, 3, and 4 fall in between as shown in
Fig. 1.5.

Figure 1.5 Gleason system of cancer cell architecture 15

Since the different parts of cancer may have different grades, pathologists grade two
areas and add the two grades. An example of grading is as follows: consider Gleason grade
7, this can be described as a combination of 3 and 4 as 3+4=7.

Here, the first score

8

represents the most prevailing grade of the tissue and the second score represents the next
most prevailing grade. Therefore, the Gleason grade varies between 2 to 10. A Gleason
grade of 6 is the most commonly seen Gleason grade. It has been reported that the DNA
content of PIN is in between the DNA content of benign glands and cancer.10 In addition, as
the number of aneuploid nuclei or abnormal number of chromosomes increases, so does the
level of PIN.

However, the proliferation activity and ploidy values (the amount of DNA

content in a cell) of PIN and carcinoma are similar to each other. The progression of PIN
stage to carcinoma stage is evident in the basal layer with an increase of mean nuclear
volume in PIN, which was discovered by Teba et al. 16 However, the nuclear features of the
luminal layer in PIN remain the same as in carcinoma.

1.1.3 Pediatric Tumors
Neuroblastoma and ganglioneuroma are peripheral neuroblastic tumors. These are
derived from immature sympathetic nervous system and adrenal gland.

Neuroblastoma,

the third most common type of cancer, occurs in embryonic neuroblasts of the sympathetic
peripheral nervous system which can spontaneously be matured into ganglioneuroma. 17 It
is a solid malignant tumor which can be observed in abdomen, around the spinal cord near
the chest region, or pelvis. Neuroblastoma has been called the “great masquerader” since
its symptoms mimic many other diseases. 18

9

Table 1.2 International Shimada classification 19,

20

According to International Neuroblastoma Pathology Classification, there are four
basic

morphological

categories:

neuroblastoma

(Schwannian

stroma-poor),

ganglioneuroblastoma-intermixed (Schwannian stroma-rich), ganglioneuroma (Schwannian
stroma-dominant),

ganglioneuroblastoma-nodular

(Composite,

Schwannian

stroma-

rich/Schwannian stroma-dominant and Schwannian stroma-poor) as described in Table 1.2.

1.1.3.1. Neuroblastoma (Schwannian Stroma-poor)
Neuroblastoma frequently occurs in infants and children. This is subdivided into 3
groups: differentiating, undifferentiated, and poorly differentiated. The poorly differentiated
and differentiating neuroblastoma are further categorized as favorable and unfavorable
cases. For favorable case, there is a probability of appropriate age maturation, and while
for biologically unfavorable peripheral neuroblastic tumors, there is no such a probability.
The survival rate of favorable neuroblastoma is much higher than the unfavorable
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histopathology. Figure 1.6 shows a pathology image of favorable neuroblastoma with poor
surrounding stroma.

Neuroblasts

Figure 1.6 Neuroblastoma with stroma poor in the background

1. Undifferentiated

Neuroblastoma:

When

a

tumor

tissue

is

composed

of

undifferentiated neuroblastic cells without identifiable neuropil (region between
neuronal cell bodies in the gray matter of the brain and spinal cord), it falls under
this subcategory. These neuroblasts have indistinct nuclei cytoplasm borders where
size can vary from small to medium.
2. Poorly Differentiated Neuroblastoma: In this category most of the tumor cells
are undifferentiated but still there is a presence of varying amount of neuropil
corresponding to Schwannian differentiation. Ganglion cells appear up to 5% of the
tumor cells but still can be distinguished from neuroblasts.
3. Differentiating

Neuroblastoma:

More

than

differentiating neuroblasts and ganglion cells.

5%

of

the

tumor

cells

are

These neuroblasts have distinct

borders of cytoplasm and they also show synchronous enlargement of nuclei and
cytoplasm.

11

1.1.3.2. Ganglioneuroma (Schwannian Stroma-dominant)
Ganglioneuroma contains distributed maturing or mature ganglion cells with
predominantly dominant Schwannian stroma in the background. This type of tumor can be
commonly seen in locations such as posterior mediastinum and retroperitoneum. However,
it is rarely seen in adrenal gland.
mature.

Ganglioneuroma can be subdivided as maturing and

Mature ganglioneuroma contains fully matured ganglion cells and Schwannian

stroma (see Fig. 1.7) while maturing ganglioneuroma has maturing ganglion cells and less
contents of differentiating neuroblasts.

Ganglions

Schwann cells

Figure 1.7 Ganglioneuroma

1.1.3.3 Wilms’ Tumors
Wilms’ tumor is the most common childhood kidney cancer.

Due to therapeutic

advancement, the survival rate in the United States has increased to 90% in 1996.
However, the survivors are at a greater risk of dying after several years. 21

Nephrogenic

rest (persistent embryonal remnants in the kidney) is considered as the precursors of
Wilms’ tumor.

When multiple or diffuse nephrogenic rests are observed, they are called

“nephroblastomatosis”.

The common characteristics of nephrogenic rest are dormancy,

maturation, involution, hyperplastic overgrowth, and neoplastic induction. 22
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1.1.4. Acanthosis Nigricans
Obesity is one of the major health problems in the USA.

According to one

overweight and obesity prevalence estimation, over two thirds of American adults are
overweight and over one third of adults are obese. 23

Among insulin-resistant diabetic

patients who also suffer from obesity, acanthosis nigricans is a very common dermatologic
condition causing skin darkening and roughening mostly occurring in the posterior (see Fig.
1.8) and lateral folds of the neck, the axilla, inframammary, groin, and other areas.

Figure 1.8 Acanthosis nigicrican skin condition in the neck area
Classically, it was described as a herald for internal malignancy, but in 1976,
acanthosis nigricans was shown to have a direct association with hyperinsulinemia. 24,

25, 26

It is considered a cutaneous marker for insulin resistant states including type 2 diabetes
mellitus and polycystic ovarian syndrome. 27, 28,

29, 30

In the year 2000, the American Diabetes Association established acanthosis nigricans
as a criterion for identifying children at risk for developing diabetes mellitus. 31,

32

It has

been demonstrated that hyperinsulinemia or insulin resistant states can lead to acanthosis
nigricans.

At higher concentrations, insulin interacts with insulin-like growth factor-1

receptors particularly on keratinocytes and fibroblasts in skin; this results in acanthosis
nigricans, a state of hyperproliferation. 33

As hyperinsulinemia is treated, acanthosis
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nigricans should improve and may entirely resolve.

However, the exact relationship

between insulin, obesity, and insulin resistance of diabetic patients is not yet fully
understood. 34

Acanthosis nigricans can occur due to several other conditions such as a

result of glandular disorder, Addison disease (deficiency of hormones from the adrenal
gland), disorder from the pituitary gland, low level of thyroid hormones, and oral
contraceptives. However, obesity remains the major cause. 35
Skin has a complex structure as shown in Fig. 1.9.

The human skin has many

layers. The three main layers are called the epidermis, dermis, and hypodermis (subcutis).

Figure 1.9 Skin Structures 36,

37

The epidermis, stratified epithelium that forms the outer layer of the skin can further
be subdivided into 5 layers, namely, stratum basale, stratum spinosum, stratum corneum,
stratum lucidum, and stratum granulosum. The bottom layer of epidermis is the stratum
basale where cell division occurs, followed by keratinization in the layer of stratum
spinosum. 38

The keratinization is the skin renewal process where daughter cells are
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transformed into pickle cells and then they die eventually. These dead cells are pushed to
the top layer of stratum corneum.

The next adjacent layer, stratum lucidum helps to

reduce friction and shear forces between stratum corneum and stratum granulosum which
can be seen in thick skin.

It also protects the skin from ultra-violet rays.

The dermis

consists of two layers; papillary layer which contains thin collagen fibers that provides
strength to the skin and reticular layer which contains thick collagen fibers that will add
support to the surrounding cells.
The flexibility of skin is due to elastic fibers which are in the reticular layer.

Hair

follicles, lymph vessels, smooth muscles nerve cells, and sweat glands also grow in this
layer.

The blood flows to the epidermis through the capillaries in the dermis.

The

hypodermis contains loosely connective tissues and bases of hair follicles and sweat glands.

1.2. Optical Techniques Used in Diagnosis
Detection and confirmation of any disease/cancer is very crucial for its successful
treatment in order to improve survival rate. Sometimes, the standard screening programs
can provide misleading results leading to wrong or over-treatments, and occasionally, to
fatal consequences. The interpretations of histological examination of biopsies, considered
as the “gold standard” for diagnosis, are often subjective and can vary significantly from
one pathologist to another. 39 Hence, it is imperative to detect the state of the disease with
a method which is objective and capable of providing results within a very short period of
time.

Optical spectroscopy techniques, namely Raman spectroscopy, diffuse reflectance

spectroscopy, etc. are very well suited for these types of goals as they are also capable of
probing diseases at cellular level.
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1.2.1 Raman Spectroscopy
Raman

spectroscopy

can

provide

information

about

the

changes

in

the

concentrations of the constituent biomolecules of tissues and detect the progression or state
of the disease. In Raman spectroscopy measurements, a monochromatic laser light incident
on a sample and the scattered light is collected and analyzed to derive the information
about the contents of the sample. A majority of the light scatters elastically; however, a
very small fraction of it scatters inelastically carrying information about the molecular
nature of the sample, their mutual interaction, and their relative concentrations in the
sample. 40

The chemical nature of molecules can be uniquely determined from their

vibrational energy levels and Raman spectroscopy has the capability to measure these
vibrational energy levels. 41,

42

Typical Raman spectra from some biopolymers and cells obtained by Notingher et
al 43 are shown in Fig. 1.10. This study demonstrates that Raman spectroscopy can become
a powerful investigation method to determine the biochemical composition of a biological
material.

Figure 1.10 A typical Raman spectra of cells and biopolymers43
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The peaks observed in a Raman spectrum of a tissue sample are often assigned to
the vibrational energy states of the chemical groups and the backbones structures of the
molecules. Table 1.3 lists the assignments found in the literature for the Raman bands (in
the 600 - 1800 cm-1 region) observed in tissue samples.

Table 1.3 Peak assignments of Raman spectra43
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A Raman mapping study was done by Jong et al using tumor and healthy bladder
tissues. 44 Figure 1.11 shows the mean spectra corresponding to those areas.

Figure 1.11 (A) and (C) are unstained and stained tissue sections which have non-tumor
and tumor areas, (B) represents matching colors and (D) average spectra: red-muscle
tissue, purple-tumor, green-collagen fiber and blue and yellow transition between the two
types44
Using near-infrared Raman spectroscopy, a significant spectral differences between
normal and dysplastic gastric mucosa tissues were found, particularly in the spectral ranges
of 850–1150, 1200–1500, and 1600–1750 cm-1, and were able to differentiate dysplasia
from normal gastric mucosa. 45

Haka et al studied freshly excised surgical breast cancer

tissues and successfully developed an algorithm to diagnose their pathological states. 46
Crowe et al reported a study of both the adenocarcinoma biopsies 47 and cell lines 48 of
prostate cancer and successfully classified the benign and cancerous cells/tissues.
The studies on nasopharyngeal biopsy tissues showed that the spectral features of
three Raman bands varied significantly when tissue changed from normal to malignant
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state 49 , and in another study on frozen tissues from larynx showed that the characteristic
Raman spectral features for normal, carcinoma, and papilloma tissues are different. 50
Rabah et al reported Raman investigation of neuroblastoma and ganglioneuroma in fresh
tissue specimens 51 and found distinct spectral differences between tumor and normal
adrenal gland. Subsequently, an investigation was done to distinguish neuroblastoma and
related tissues from healthy tissues in fresh vs. frozen specimens. 52

A high correlation

between fresh and frozen tissues was found and a faster method of identifying pathological
conditions was developed. In addition, normal kidney specimens were distinguished from
Wilms’ tumor. 53 In this study, both fresh and frozen tissue specimens from Wilms’ tumor
treated or untreated, normal kidney, and other related renal tumors which show various
similar morphologies were used, but still Raman technique could distinguish between them
successfully.

1.2.2. Diffuse Reflectance Spectroscopy
Diffuse

reflectance

spectroscopy

provides

information

physiological parameters and the biochemical composition.

about

the

relevant

When light is incident on a

sample, reflection, scattering, absorption and transmission through the sample can occur.
The reflection of light obeys the law of reflection and the transmission of light obeys Snell’s
law. The Fresnel’s equations describe reflection and transmission of light through multiple
media having different indices. 54

Further, the reflection can be either specular or diffuse.

Specular reflection is the reflection off of a smooth or a glossy surface in which an incoming
ray is reflected into a single outgoing direction obeying the law of reflection. Conversely,
when parallel rays of light are incident on a rough surface, the direction of the reflected light
rays may differ due to different orientations of the surface normals for various incident rays.
This type of reflection is called “diffuse reflection”.
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Many theoretical models have been developed to describe the diffuse reflectance
phenomenon. The model proposed by Farrell et al in 1992 55 is quite successful in extracting
tissue optical properties.

This model allows determination of optical properties of tissues

from diffuse reflectance spectra, using only the shape of the reflectance curve. This model
was improved by Zonios et al in 1999 56 and was applied to biological tissues, human colon
specimens of normal colonic mucosa, and adenomatous colon polyps (precursor lesion) by
introducing four main parameters: hemoglobin concentration, hemoglobin saturation,
effective scatterer density, and effective scatterer size of the tissue.
Hemoglobin and melanin are the main chromophore absorbers in the skin.
Absorption (scattering) can be explained using the characteristic parameter called
absorption (scattering) coefficient μa (μs-cm-1) which is defined as the probability of photon
absorption (scattering) per unit path length in a medium. This coefficient depends on the
cross section and the number density of the absorbers (scatterers).3 Since hemoglobin can
be either in the form of oxyhemoglobin or deoxyhemoglobin, their concentrations can be
estimated using the known absorption coefficients of biological tissues at different
wavelengths. Subsequently, quantitative assessment of human skin melanin, hemoglobin,
and light scattering properties were determined using diffuse reflectance spectroscopy in the
visible and near-infrared regions based on the same analytical model. 57

Since all these

experiments were done using fiber optic probes, attempts to design a ball lens coupled fiber
optic probe for depth resolved spectroscopy of epithelial tissues were also reported. 58,

59

Katika et al investigated optical properties of human skin using steady state directional
diffuse reflectance through numerical simulations using a seven-layer skin model. 60 Nuclei
size and density distribution of the mucosal tissues were also extracted through the
backscattered light by analyzing the frequency and the amplitude of the fine structure. 61
Benign and malignant breast tissues were also investigated through diffuse
reflectance spectroscopy.

Brestlin et al found adipose tissues do not contain -carotene,
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and thus, an indicator to differentiate malignant from benign. 62 In another in vivo breast
cancer study, hemoglobin saturation and total hemoglobin content was determined from the
diffuse spectra and found that the hemoglobin saturation is significantly lower in benign
tissues and also negatively correlated with the tumor size. 63

1.2.3. Fluorescence Spectroscopy
Fluorescence spectroscopy has been widely tested to characterize skin. The principal
fluorophores of the skin are tryptophan, pepsin digestible collagen cross-links, collagenase
digestible collagen cross-links, elastin cross-links, and NADH. When characterizing the skin
fluorophores, the penetration depth of light plays an important role.

Usually, skin

penetration is about 1 mm at about 700 nm and this depth decreases as the wavelength
decreases. Fluorescence excitation spectra showed three excitation bands, 295, 335, and
370 nm in a mouse skin investigation 64 .

Hamzavi et al observed that blue vitiligo

characterization can be done much better using the autofluorescence spectroscopy
compared to the reflectance spectroscopy. 65

A high correlation between fluorescence and

skin pigmentation and redness was also seen.

Thus, once the influence of skin

pigmentation and redness was corrected a trend between the 375 nm fluorescence and the
age can be observed. 66

Research Goals
The goal of our research work is to investigate the applications of (1) Raman
spectroscopy to diagnose head and neck squamous cell carcinoma, prostate cancer, and
pediatric tumors, and (2) diffuse reflectance spectroscopy to detect acanthosis nigricans
skin disorder.

In Chapter 2, the theoretical background is presented and Chapter 3

summarizes the instrumentation of both Raman spectroscopy and diffuse reflectance
spectroscopy followed by the tissue processing and data collection. All the research data
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are analyzed using chemometric methods such as principal component analysis and
discriminant function analysis which is explained in detail in Chapter 4. Chapters 5, 6, and
7 summarizes the results of Raman spectroscopic investigations of ex vivo tissue
characterization in head and neck squamous cell carcinoma, prostate cancer, and pediatric
tumors, respectively whereas Chapter 8 presents the diffuse reflectance and colorimetric
investigation of acanthosis nigricans in vivo. Chapter 9 presents the conclusions and future
work.
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CHAPTER 2
RAMAN SPECTROSCOPY AND DIFFUSE REFLECTANCE SPECTROSCOPY
The theory of Raman scattering is well worked out and the principles of Raman
spectroscopy applied to polyatomic molecules, and solids are well explained in number of
books.3,

67, 68

Similarly, the principles of diffuse reflectance spectroscopy and its biological

applications have been described in numerous articles and book.3,

55-61, 69

Here, a brief

description of the principles of these techniques will be given.

Light is an electromagnetic wave.

When light is incident on a surface of a bulk

material, various processes can happen to a varying degree depending on the nature of the
surface and the wavelength of the light used.

In this research work, the interest lies on

absorption and scattering processes.

Excited State
Vibrational energy levels

Absorption

Nonradiative
relaxation

Raman
Fluorescence

Virtual state

Figure 2.1 Jablonski energy diagram3

When a light wave of sufficient energy is incident on a molecule or an atom, it can
cause a transition of an electron from the ground state to an excited state. This excitation
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process is commonly referred as an electronic transition.

In a molecule, the atoms can

rotate and vibrate with respect to each other. Thus, for a given electronic state, there are
associated discrete vibrational and rotational energy levels, which can be thought of as
being packed on top of each electronic level. The excited electrons can relax in radiative or
non-radiative processes. If the excited electrons relax without producing photons, then the
relaxation process is called non-radiative relaxation.3
However, if the excited electron relaxes to the ground state spontaneously by
producing another photon, it is called fluorescence.
these relaxation processes.

Figure 2.1 schematically describes

Usually, fluorescence light is shifted to longer wavelengths

relative to the excitation light which is commonly referred to as red shift. This is due to the
fact that a part of the energy is lost in the excited state due to molecular vibrations.
However, if the electrons in the excited state or ground state are in a higher vibrational
state due to thermal energy at high temperatures, this may not be the case.

Then, the

emitted light will have a shorter wavelength than the incident light.

2.1 Raman Spectroscopy
The phenomenon of Raman scattering was discovered by Sir Chandrasekhara
Venkata Raman in 1928.40 When a photon is incident on a polarizable molecule it can excite
(de-excite) vibrational modes of the molecules, resulting in scattered photons with
decreased (increased) energy by the amount of the vibrational transition energies. Raman
scattering is an inelastic scattering process as there is an energy exchange between the
molecule and the photon.

If the scattered photon has the same energy as the incident

photon, the scattering is called Rayleigh scattering which is an elastic scattering process.3
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Virtual States

E

Vibrational States
Ground State
Rayleigh
scattering

Stokes
Raman
scattering

Anti-Stokes Infrared
absorption
Raman
scattering

Figure 2.2 A schematic illustration of scattering and absorption processes

This inelastic scattering is further distinguished as Stokes scattering or anti-Stokes
scattering depending on the loss or gain in energy of the scattered photon.

In Stokes

scattering, the electron is excited to a virtual state. Since, this virtual state is unstable the
electron may quickly decay into a higher vibrational instead of the initial state as shown in
green arrow in Fig. 2.2. Here, the energy is absorbed by the molecule. Thus, the emitted
photon has a longer wavelength or in other words the scattered photon is red shifted. It is
common to use the term “red shifted” or “blue shifted” if the energy of the scattered light is
lower (longer wavelength) or higher (shorter wavelength). If the scattering results in an
excitation from an initial excited vibrational state to a virtual state and subsequent deexcitation to a ground state or a lower excited state than the initial state, then the emitted
photon has more energy than the absorbed photon (blue-shifted), and this is called antiStokes scattering.

However, the number of electrons in the excited vibrational state

depends on the Boltzmann distribution.67
It is important to distinguish scattering and absorption processes (Fig. 2.2). Infrared
absorption involves molecules making direct transitions from one vibrational state to a
higher vibrational state by absorbing a photon of exact energy equal to the difference
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between the vibrational states (~ 12–400 meV).

In other words, the incident photon

energy exactly coincides with the energy difference between vibrational states.

This is

shown schematically in Fig. 2.2 along with the difference between Stokes and anti-Stokes
Raman scattering and Rayleigh scattering.

Figure 2.3 Graphical representations of Raman active and inactive modes.67

The basic necessary condition for observing the Raman scattering is that the
polarizability (  ) must change during vibrations of the molecules. The bigger the change,
the greater the effect is. However, for infrared absorption, a change in dipole moment (μ)
causes the absorption68 and it is a necessary condition.

Usually, for Raman scattering,

symmetric stretching causes the most intense scattering whereas for infrared absorption
asymmetric stretching causes the greatest.

In centro-symmetric molecule, both Raman

scattering and infrared scattering cannot occur at the same time.

Thus, both these

techniques can be used to get complimentary information about a particular form of
vibration in a molecule. 70, 71
If a given non-linear molecule contains N atoms in this molecule, then there are 3N6 possible vibrations (degrees of freedom) except for a linear molecule where there are 3N-
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5 possible vibrations.

Molecular vibrations are periodic motions of the atoms in a

molecule.68
The classical explanation of the Raman scattering is as follows. When an
electromagnetic wave interacts with a molecule, the electron cloud around molecule
distorts, thus, an induced dipole moment can occur.

This induced dipole moment is a

function of the polarizability and the incident electric field, E.71

P  E ------------------------------------------------------------------------------(2.1.1)
The electric field of the incident electromagnetic wave can be written as,

E  E 0 cos(2 0 t ) ------------------------------------------------------------------(2.1.2)

 o is

the frequency of the electromagnetic wave and E0 is its amplitude. Thus, the

induced dipole moment can be expressed as

P  E 0 cos(2 0 t ) -----------------------------------------------------------------(2.1.3)
The perturbation of the electron cloud depends on relative location of the atoms of
the molecule.71

Hence, the polarizability of the molecule depends on the instantaneous

position of the atoms in it. Thus, by using the Taylor expansion, the polarizability can be
approximated as

  0 


dQ ---------------------------------------------------------------------(2.1.4)
Q

where, dQ is the displacement of the atoms about their equilibrium position. For a
given vibrational mode, dQ can be written as

dQ  Q0 cos(2 vib t ) ----------------------------------------------------------------(2.1.5)
where

 vib is

the vibrational frequency of the molecule and Qo is the maximum

displacement about the equilibrium. By substituting, the polarizability is written as,

  0 


Q0 cos(2 vib t ) --------------------------------------------------------(2.1.6)
Q
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Hence, induced dipole moment can be expressed as


Q0 E 0 cos(2 0 t ) cos(2 vib t )
Q
---------(2.1.7)
 Q0 E 0
cos[2 ( 0   vib )t )]  cos[2 ( 0   vib )t ]
  0 E 0 cos(2 0 t ) 
Q 2
P   0 E 0 cos(2 0 t ) 

This equation illustrates that there are three frequencies which contribute to the
induced dipole moment. They are

 o , ( o   vib ) , and ( o   vib ) .

These three frequencies,

respectively, are the scattered frequency, which coincides with the incident light frequency
(Rayleigh scattering), the Stokes and the anti-Stokes scattering frequency.67
The energy difference between the incident photon and the Raman scattered photon
is defined as the Raman shift.

Since energy and frequency are proportional, this is also

known as the vibrational frequency of the scattered molecule (cm-1). Raman shift is given
by

 

where



1

incident



1

scattered

-------------------------------------------------------(2.1.8)

is called the wave number in units of cm-1.

For Raman spectra, vibrational

transitions appear in the 104 to 102 cm-1 region.
Quantum mechanically, vibrational energy levels of a molecule can be determined by
solving the Schrödinger equation for a molecule. In a molecule, the chemical bond between
the atoms can be considered as a spring (with spring constant K) and the motion of the
atoms then can be described by Hooke’s law.

In treating diatomic molecule as a single

particle with reduced mass μ, the Schrödinger equation for such a quantum mechanical
system (a simple harmonic oscillator) can be written as,

1
d 2 8 2  


E

Kq 2   0 ----------------------------------------------------(2.1.9)

2
2
2
dq
h 
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The Eq. 2.1.9 can be solved for the energy eigenvalues or frequencies of the system,




which are given by E n  h  n 
quantum number.

1
1
 and  
2
2

K

.

Here n is called the vibrational

For a quantum mechanical simple harmonic oscillator, the allowed

transitions are n  1 , whereas for anharmonic systems

n  2,3,... can be observed

which are commonly known as overtones.67

2.2.1 Fourier Transform Raman Scattering
Fourier transform Raman scattering is regular Raman scattering with a different
mechanism for collecting and analyzing the scattered light.

Fourier transform Raman

methods utilize Michelson interferometers and Fourier transform processors.

Once the

scattered light from the target is collected and the elastically scattered light is removed, it
goes through a Michelson interferometer.

In Michelson interferometer, the incident laser

beam is split into two beams where one incident on a fixed mirror and the other on a
varying mirror. The reflected beam from these two mirrors, combine at the beam-splitter
producing a sinusoidal interference pattern.

Then, this signal is detected through an

infrared detector and Fourier transformed to get a Raman spectrum. 72

2.2.2 Confocal Raman Micro-spectroscopy
Confocal Raman micro-spectroscopy allows one to obtain inference-free Raman
spectra in two or three dimensional images of small specimens which are embedded in a
strong scattering media.

The confocal microscopy configuration consists of two pinhole

apertures to remove the residual scattered light generated from out of focus points in the
sample.

When this is utilized in conjunction with a spectrometer to analyze the Raman

scattered signal, the improvement in spatial resolution and depth discrimination can be
achieved. These are the major advantages for using this technique.72
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2.2.3 Infrared Absorption Spectroscopy
Infrared (IR) absorption spectroscopy is another valuable vibrational spectroscopic
method which is used to identify molecular structures.68

The main drawback of using IR

spectroscopy in biological tissues is the high absorption of water and CO2 in the
fundamental frequency range.

The water absorption bands lie in the 400-1800 cm-1

wavenumber region, and thus interfere with bands due to biomolecules of interest. In fact,
IR spectra need to be corrected for absorption due to water molecules and CO2 in air. This
makes it difficult to use IR spectroscopy in ex vivo or in vivo fresh biological tissue
characterization for cancer diagnostic purposes.

Further, as the Fourier transform IR

spectrometers are based on the use of Michelson interferometer, it is difficult miniaturize
them to make them hand-held and portable.

Nevertheless, both Raman and IR

spectroscopy are needed to determine the complete set of vibrational modes of molecules
with center of symmetry, as the Raman and IR activity of modes in such molecules is
mutually exclusive.70

2.3 Diffuse Reflectance Spectroscopy
When a laser beam hits a sample, reflection, scattering, absorption, and transmission
through the sample can occur. The reflection of light obeys the law of reflection, i.e. the
angle of incidence is same as the angle of reflection. The transmission of light obeys Snell’s
law, n1 sin  1  n 2 sin  2 where θ1 and θ2, are angles of incidence and refraction respectively,
and n1 and n2 are refractive indices of the two media. When the light travels in multiple
media having different indices, its reflection and transmission behavior is described by
Fresnel equations. 73 If the light is incident close to the normal incidence, then the reflection
(R) and transmission (T) coefficients can be described by the following equations;
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n n 
R   1 2 
 n1  n2 
T  1 R 

2

----------------------------------------------------------------------(2.3.1)

4n1n2
n1  n2 2

-------------------------------------------------------------(2.3.2)

Reflection can be either specular reflection or diffuse reflection. Specular reflection is
defined as reflection off of smooth surfaces such as a glossy surface in which an incoming
ray is reflected into a single outgoing direction obeying the law of reflection as shown in Fig.
2.4.

Specular Reflection
(Smooth surfaces)

Diffuse Reflection
(Rough surfaces)

Figure 2.4 Specular reflection and diffuse reflection

When parallel light hits on a rough surface, the direction of the reflected light may be
different although each ray follows the law of reflection. This is due to different orientations
of the surface, and thus, the normals for the incident ray are different. This reflection is
called diffuse reflection.

The diffuse reflectance is defined as the probability of photon

reemission per unit surface area from a scattering medium. 74

This is also known as the

relative diffuse reflectance and we will use these measurements to find the optical
properties of biological tissues.
The absorbers or the chromophores in the targeted tissue capture energy of certain
wavelengths (λ).

The main chromophores of skin are melanin, DNA, amino acids,

hemoglobin, etc. 75

In a tissue, the absorption at certain wavelengths will be higher than
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the other wavelengths depending on the chromophores present. To arrive at the absorption
spectrum, we first consider the analytical form of a diffuse reflectance spectrum.
The diffuse reflectance spectrum of skin at a given site, R(λ), can be calculated from
the equation below, 76

R   

S     Sdark   
---------------------------------------------------------(2.3.3)
S ref     S dark   

where, S(λ) is the measured spectral signal of the reflected light at each wavelength, Sdark
(λ) is the dark correction obtained from a spectrum of a dark (0% reflectance) standard,
and Sref(λ) is the reference reflectance standard obtained from a white (100% reflectance)
standard.76
The absorption spectrum A(λ) of the tissue can then be calculated as the negative of
the logarithm base 10 of R(λ).76

A      log10  R     ---------------------------------------------------------------(2.3.4)
Melanin concentration is calculated from the slope of this absorption spectrum in the
620-720 nm range. 77 The absorption spectrum in this spectral range includes both melanin
and other scattering components.
Scattering is a change in the direction of incident light caused by variations in the
refractive index between layers, cellular components, and the extracellular matrix such as
collagen, elastin fibers, erythrocytes, and melanosomes.

Scattering component can be

explained using the scattering coefficient μs (cm-1), defined as the probability of photon
scattering in a medium per unit path length.74 The inverse of the scattering coefficient is
known as the mean scattering length.
μs = a x λ-b -------------------------------------------------------------------------(2.3.5)
Here, a and b represent constants which are characteristics of the tissue. The value
of a can be on the order of 104–105 and whereas b may vary between 1.2 and 1.5. 78 This
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scattering coefficient also depends on the scattering cross section and the scatterer number
density.3
Hemoglobin can exist as oxyhemoglobin or deoxyhemoglobin depending on whether
it

has

a

bound

oxygen.

The

apparent

concentrations

of

oxyhemoglobin

and

deoxyhemoglobin can be calculated from the melanin-corrected absorption curve using the
known extinction coefficients for these molecules and the intensity of the absorption curve
at the maxima of absorption for these two molecules: 560 and 580 nm.77 The hemoglobin
concentrations can be estimated using absorption coefficients of biological tissues at
different wavelengths as follows.3

 a 1   ln(10) ox (1 )C ox  ln(10) de (1 )C de ---------------------------------------(2.3.6)
 a 2   ln(10) ox (2 )C ox  ln(10) de (2 )C de --------------------------------------(2.3.7)
Here εox (cm-1M-1) and εde are molar extinction coefficients (probability of photon
interaction with a medium per unit path length) which can be obtained from experimental
curve

of

molar

extinction

coefficient

vs.

wavelength

for

each

deoxyhemoglobin, and Cox and Cde are their molar concentrations.

type

of

oxy

and

Here, μa (cm-1),

absorption coefficient is defined as the probability of photon absorption per unit path length
in a medium.

The inverse of the absorption coefficient is commonly known as the mean

absorption length. This coefficient depends on the absorption cross section and the number
density of the absorbers.
scattering.

Note that extinction coefficients include both absorption and

Once the concentration of oxy and deoxyhemoglobin are determined, the

oxygen saturation (SO2) and the total concentration (CHb) can be calculated as follows.3

SO2 

C OX
-------------------------------------------------------------------(2.3.8)
C OX  C de

C Hb  C OX  C de ---------------------------------------------------------------------(2.3.9)
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CHAPTER 3
INSTRUMENTATION AND DATA COLLECTION
In this chapter, the Raman spectroscopy instrumentation and the diffuse reflectance
spectroscopy/colorimetry apparatus used in this work as well as data collection and
analyses are described.

In addition, the tissue preparation for the Raman spectroscopic

measurements and collection of data from acanthosis nigricans patients are also described.

3.1 Instrumentation
3.1.1 Raman Spectroscopy
The basic elements a of a Raman spectrometer include a source of excitation
wavelength (a laser source), a band-pass or a line filter to filter out the unwanted laser
lines, a grating to disperse the collected scattered light, a notch filter to eliminate the
intense elastically scattered (Raleigh) light, and a detector to record the spectrum. Often a
position sensitive charge coupled detector (CCD) is used to record the entire dispersed light
(spectrum) simultaneously.

There are other detectors in use, such as a photomultiplier

tube, but the recording the spectrum with it, is a time consuming process as the only one
point of the spectrum is measured at a given time. The CCD increases the speed of data
acquisition. The spectrometer control and data acquisition is accomplished by a computer
equipped with appropriate software. A schematic of a Raman spectrometer is shown in Fig.
3.1.

Sample
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Raman Spectrum
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Figure 3.1 Schematic diagram of a Raman instrument 79
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The performance of a CCD detector depends on quantum efficiency (QE) and its
operating temperature.

The dark current (noise) of a detector depends on its operating

temperature, and thus, liquid nitrogen cooled detectors have a superior performance
characteristics compared to their air cooled counterparts. The dark current originates from
thermal agitation. 80 Hence, in liquid N2 cooled CCD detectors, the dark current is very low,
less than 1 electron/pixel/hour. There is a type of noise associated with dark current, which
is called dark noise. This dark noise occurs due to statistical variations in dark current.80
Thus, dark noise can be minimized by cooling. The QE is ratio of number of photoelectrons
generated to the number of photons strikes on a photoactive surface of the detector. As
CCD chip is made of silicon, the QE is very high, about 45-50% at 750 nm and depends on
several factors such as energy band gap of the semiconductor sensing light.
For the work reported in this thesis, we have used two different Raman
spectrometers to record the spectra from frozen and archived human tissues.

One is a

Renishaw RM1000 Raman microscope-spectrometer equipped with a 785 nm near-infrared
laser excitation source and this instrument is housed in the Children’s Hospital of Michigan,
Detroit, MI (see Fig. 3.2). The other is a Jobin-Yvon Horiba Triax550 Raman spectrometer
system equipped with a 514.5 nm argon-ion laser excitation source, and it is housed in the
Department of Physics and Astronomy, Wayne State University (see Fig. 3.3). Both these
instruments are capable of working with 514.5 nm and 785 nm excitations laser
wavelengths.

Renishaw RM1000 InVia Raman Microscope
The Renishaw Raman system is a commercial system and consists of a Leica
microscope, air cooled 578x385 pixel Charge-Coupled Device (CCD), ProScan II motorized
xy stage and a computer equipped with Wire2 software to control the spectrometer and
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acquire the Raman spectra. The microscope is furnished with three objectives 5x, 20x, and
50x.

Figure 3.2 A schematic of the Renishaw RM1000 Raman spectrometer 81

We used the 50x objective with a 0.5 numerical aperture (NA) for all the Raman
measurements taken with this instrument. NA is defined as the product of the refractive
index, n (n of the medium between the lens and the specimen) and sin (α), where α is half
of the cone of the collected light. 82

It is an important parameter in deciding the type of

objective one wants to use for their Raman measurements.

A high NA objective collects

much more scattered light compared to a low NA objective, 83 thus, reducing the sample
exposure time.
A schematic of the Renishaw Raman spectrometer is shown in Fig. 3.1. We used the
1200 lines/mm grating to disperse the scattered light. The maximum power of the GaAs
laser source is about 500 mW with stability less than 1 cm-1. The power at the sample is
about 30 mW and the resolution of the Raman signal is about 3.5 cm-1.

With a 50x

objective the instrument focuses the laser onto an area of 2 x 20 µm2 at the sample. As the
focal length of the 50x objective is 1 mm, it was chosen to avoid accidental contacts with
the samples.
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Jobin-Yvon Horiba Triax550 Raman Spectrometer System
The Jobin-Yvon Horiba Triax550 Raman spectrometer is a triple grating spectrometer
equipped with 2400, 1200, and 150 grooves/mm gratings which can be selected by the
software.

The spectrometer is coupled to an Olympus BX41 optical microscope and the

laser source with optical fibers. The CCD detector (2000x800 pixels) is cooled with liquid
nitrogen and the detector operating temperature is ~136 K. The spectrometer is controlled
with a computer equipped with Labspec software for control and acquisition of Raman
spectra.

We used a 100x long working distance (3.4 mm) objective with 0.8 numerical

aperture for recording the Raman spectra.

Again, the choice of long working distance

objective was to avoid any contact between the objective lens and the tissue specimen.

Figure 3.3 A physical set-up of the Triax550 Raman spectrometer

Triax550 can disperse the signal 1.55 nm/mm at 514.5 nm with a 1200 g/mm. The
resolution is of 0.03 nm. 84 The focal length of this spectrometer is 550 mm and the input
aperture of the monochromator (F number or the focal length divided by the effective
aperture diameter) is F/6.4.

If the focal length is longer, then the resolution becomes

better. It is note that the light collecting power increases with the inverse square of the F
number.
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The spectrometer can record a spectral range of ~1400 cm-1 without moving the
grating (static scan).

The microscope focuses the laser beam to a circular spot of ~1 µm in

diameter on the sample. The Raman intensity is directly proportional to the forth power of
the scattered wavelength.67

Thus, the Raman intensity increases as the wavelength

decreases. This is one of the advantages of using a shorter wavelength excitation source.
However, the fluorescence background effect is larger for 514.5 nm compared to 785 nm
excitation wavelength.

This can be minimized by acquiring data from a smaller sample

volume or by quenching, i.e. delivering laser light onto the specimen for a certain time
period before collecting data 85 (Note that quenching can be done only for the samples which
are not prone to damage due to long laser exposure time).
Both these Raman instruments are calibrated using the known silicon peak (520.5
cm-1) prior to each measurement. This Si calibration procedure is described in more detail
in section 3.3.1.

3.1.2 Diffuse Reflectance Spectroscopy and Colorimetry
The diffuse reflectance spectroscopy apparatus consists of a HL-2000 Ocean Optics
deuterium tungsten halogen lamp for skin illumination, a broadband spectrophotometer
(USB 2000 light detector; BWTEK, Inc., USA) capable of detecting absorbance in the
wavelength range 350-850 nm (visible to near infrared region), a bifurcated fiber optic
probe for light delivery and scattered light collection, and a computer. The output end of
the bifurcated fiber bundle which is placed in contact with the skin was 2.5 mm in diameter.
The absorbance spectra are calculated from the measured scattered light spectrum by a
custom Labview 8.0 (Labview Inc.) program (Johnson and Johnson, NJ, USA). A schematic
of the USB 2000 spectrometer is shown in Fig. 3.4.

38

Figure 3.4 A schematic of the interior of the USB 2000 spectrometer. The key optical
components are representing through 1-8: the entrance fiber, the entrance slit, an optical
filter, the collimating mirror, the grating, the camera mirror, and the detector array 86
The USB2000 spectrometer consists of a holographic 1200 diffraction grating and a
one dimensional CCD detector array with 2048 pixels. The spectral resolution is about 0.5
nm.

The F number of the optical fiber is F/2.3 and matches with F number of the

collimating mirror.86

Prior to data acquisition, the spectrophotometer is also calibrated

using pure black and pure white tile standards to obtain a dark spectrum and a highreflectance spectrum, respectively.

Colorimetry
The colorimeter apparatus consists of a CM-2600d spectrophotometer (Konica
Minolta CM-2600d, Osaka, Japan) which utilizes a Xenon arc lamp as a source of light for
illuminating the skin and a computer. Scattered light is collected by the CM-2600d through
an integrating sphere whose internal surface is coated with a barium sulfate coating to
make the light diffuse uniformly. 87
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Figure 3.5 A schematic of the integrating sphere system with SCI and SCE options87

Figure 3.5 shows the optical geometries, where the reflected light (in all directions)
is collected (SCI-specular component included) or excluding the specular reflection (SCEspecular component excluded). This instrument uses the standard tristimulus color analysis
method utilizing the L*a*b* color system.
(525 nm), and red (610 nm).

The primary colors are blue (450 nm), green

The numerical parameters L*, a*, and b* represent,

respectively, a color’s darkness to lightness, its green to red color component, and its blue
to yellow color component.87 A circular patch of skin 8 mm in diameter is illuminated by the
CM-2600d instrument.

This instrument can record both SCI and SCE measurements

simultaneously (see Fig. 3.5). Similar to diffuse reflectance spectroscopy, the colorimeter is
also corrected for detector dark current and calibrated with a standard white target prior to
measurements on every patient.
The apparatus of both these instruments are shown in Fig. 3.6 together with the size
of the each probe.
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Figure 3.6 Left: DRS setup with spectrometer, light source, calibration plate, bifurcated fiber
optic cable, and laptop; a close-up of DRS probe showing 2.5 mm fiber core. Right:
Colorimeter and a close-up of colorimeter 8 mm aperture 88
3.2 Tissue Processing
Raman investigations on head and neck squamous cell carcinoma (HNSCC), prostate
cancer, and pediatric tumors were carried out using human tissue specimens.

All these

human tissue investigations are conducted under the established rules of Wayne State
University Human Investigation committee (HIC), Institutional Review Board (IRB), and
HIPAA (Health Insurance Portability and Accountability Act) regulations (IRB protocol
numbers are 0705004871 and 0810006496).

In pediatric tumor investigation, we have

studied frozen and formalin fixed paraffin processed (FFPP or deparaffinized) tissues from
the same patients. For the Raman spectroscopic evaluations of HNSCC and prostate cancer
specimens, only the FFPP tissues were examined as there were no frozen tissues available.
As acanthosis nigricans research was done in vivo, tissue processing was not necessary.
For the investigation of HNSCC and prostate cancer, the samples were obtained from
Karmanos Cancer Center and Harper University Hospital in Detroit, MI and for pediatric
tumors, the tissue specimens were obtained from the Children’s Hospital of Michigan.
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3.2.1. Pediatric Tumors
The goal of this work was to explore the feasibility of applying the Raman
spectroscopy for diagnosis using the deparaffinized tissues. It is known that archiving the
tissues using formalin fixing and paraffin processing leads to alteration of the biochemical
content of the tissues. Thus, a comparison of the Raman spectra of FFPP or deparaffinized
archived tissues with the corresponding fresh tissues would give information about the
nature of the alterations.

We have studied the frozen tissues of normal adrenal gland,

neuroblastoma, and ganglioneuroma from three different patients, and subsequently
preserved the same tissues using formalin fixing and paraffin embedding, and again
investigated them after deparaffinizing/FFPP.

The details of the procedure used are

explained below.

Frozen Tissue Specimens
The specimens were thawed for about 20 minutes and then the desired frozen
sections were cut with a microtome using optimal cutting temperature (OCT) solution.

In

each tissue specimen from a given patient, a 5 μm thick section was cut and stained with
Haematoxylin and Eosin (H&E) for pathological examination and additionally three adjacent
10 μm thick parallel sections were cut for Raman measurements.

Then, the remaining

tissue specimen, keeping the same orientation, was put in formalin for about 24 hours and
subsequently preserved in paraffin wax at Karmanos Cancer Center, Detroit, MI.

Deparaffinized/FFPP Tissues
Once the tissues are embedded in paraffin wax these tissue blocks were processed
again to remove paraffin wax from the tissue using several ethanol methanol baths. It is
important to remove all the wax from the specimens because paraffin gives a strong Raman
bands and any residual paraffin left in the specimens interferes with the Raman bands of
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the specimens’ leading to misinterpretation. Similar to frozen tissue sectioning, four parallel
tissue layers, one for H&E staining and the rest for the Raman spectroscopic investigation
were cut from each specimen. It is important to note that these four tissue sections are
adjacent to the four sections that were cut in the frozen state prior to preserving the tissue
in paraffin.

3.2.2 Head and Neck Squamous Cell Carcinoma and Prostate Cancer
For head and neck squamous cell carcinoma and prostate cancer investigation, only
formalin-fixed paraffin-embedded tissue blocks were used. The archived specimens
embedded in paraffin were processed before recording their Raman spectra. Similar to the
frozen vs deparaffinized study, for each specimen two adjacent parallel tissue sections were
cut and deparaffinized, where one of the sections was stained using H&E for histological
examination and the other unstained section was put on a stainless steel substrate for
Raman spectroscopic studies.

We used stainless steel substrates because it gives less

background signal and no characteristic peaks of its own compared to glass, quartz, or
sapphire.

Unstained section

H&E stained section

Figure 3.7 Pathological images of H&E stained tissue section and unstained tissue section 89
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When collecting data, pathologically identified regions of the H&E stained tissue were
used as a guide to identify the corresponding regions in the unstained tissue section as
shown in Fig 3.7. For the pediatric tumor project Drs. R. Rabah (University of MichiganAnn Arbor) and J. M. Poulik (Children’s Hospital of Michigan) made the ink markings
identifying appropriate pathology regions on the H&E slides.

Dr. C-H. Chang (Children’s

Hospital of Michigan) also served as an external reviewer of the pathology diagnosis. For
the prostate cancer project, Drs. W. Sakr and S. Sethi (Karmanos Cancer Center) marked
the desired regions and Dr. D. Shi (Karmanos Cancer Center) also reviewed the H&E slides.
Staining is an important and necessary process in histopathology examination.
Hematoxylin and Eosin are commonly used dyes for tissue staining. Haematoxylin gives a
blue color to the nucleus whereas eosin dye makes the rest of the content (cytoplasm,
collagen, etc.) pinkish in color, thus, providing contrasts to identify the morphology and
diagnose a state of the disease. Pathologists rely on being able to see the morphology for
disease diagnosis.

However, stained tissues produce strong fluorescence from eosin dye

and not suitable for Raman spectroscopic studies. 90

Often, the fluorescence is so strong

that the Raman signal cannot be discerned or the detector gets saturated even for brief
exposure. Thus, we only make Raman measurements on unstained frozen or deparaffinized
tissues.

3.2.3 Acanthosis Nigricans
Spectroscopic

investigation

of

acanthosis

nigricans

skin

disease

is

done

in

collaboration with Department of Dermatology, Henry Ford Hospital, Detroit, MI under the
leadership of Drs. I. Hamzavi and H. Lim. In this research work, we test patients’ skin sites
in vivo using a diffuse reflectance spectrometer and a colorimeter.
processing is not required as in the Raman investigations.

Consequently, tissue

However, it is a necessary

requirement that all the patients be in an insulin resistant condition, meaning elevated
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fasting insulin levels with normal fasting glucose levels. The patients with type 1 diabetes,
women who were lactating, pregnant, or planning to become pregnant, and those who were
hypersensitive to oral metformin medication were excluded from this study.
In this AN study, eight female patients, ages 12 years and older with AN as
diagnosed by a dermatologist were enrolled. During the course of this research, all patients
were consulted by an endocrinologist for treatment of their hyperinsulinemia with diet
control, weight reduction and/or oral metformin. Patients’ consents were obtained through
an informed consent form and all study-related procedures were explained before enrolling
them in the study.

3.3 Data Collection and Processing
In this section, the collection, processing and analyses of data using statistical
analysis are explained. The methods used in both Raman investigations and the diffuse
reflectance studies are described.

3.3.1 Raman Data Collection
The Raman spectrometers were calibrated prior to each recording session, using well
known silicon peak at 520.5 cm-1. For this purpose a small piece of the silicon wafer was
used, and any correction needed was applied using the spectrometer control software. The
Renishaw Raman system has an automated “health check” routine that performs an
calibration and alignment check and makes necessary adjustment/alignment so that silicon
peak appears at the expected position with optimum intensity.
When targeting a particular region of the tissue, all three objectives of the
microscope (5x, 20x, and 50x) are used. First the desired region of the unstained tissue
section is located using the H&E slide with 5x objective.

After final focusing and

adjustments, a Raman spectrum is taken using the 50x objective.

In order to achieve a
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better signal to noise ratio, three accumulations of 20 s each averaged to obtain a
spectrum.

The range Raman shift range of 400-1800 cm-1 is usually considered as the

“biological window” because it contains most of the useful fundamental Raman active modes
of biological molecules. However, we collected the data in the range of 500-1900 cm-1 for
fluorescence background subtraction and for the statistical analysis.

While only the 600-

1800 cm-1 region was used for spectral identification, the extra coverage was to minimize
artifacts at the boundaries of the spectral region which can arise from the computerized
background subtraction of the spectra.
For the Raman spectral data obtained from the Jobin-Yvon Horiba Triax550 Raman
spectrometer system, a 40 second integration time was used and spectra were averaged
over five accumulations which gave the optimal signal to noise ratio of a Raman spectrum.
Care was taken to ensure that each spectrum was collected from a new location on the
tissue. The spectra were recorded in the 428–1812 cm–1 region that involved no motion of
the grating (static scan), thus, avoiding any spurious Raman shifts because of backlash
errors associated with grating motions.

The spectrometer does not have an automated

“health check” routine and thus the alignment and calibration using silicon were done
manually.

3.3.2 Raman Data Processing
The raw Raman spectra (shown in Fig. 3.8 (a)) often contain a large fluorescence
background and occasionally some unexpected peaks (noise) may appear due to stray light
or cosmic. Therefore, before analyzing the data, each spectrum is examined manually and
the unusable spectra are removed from the data set. This is followed by the removal of
obvious noise peaks and the background fluorescence of the selected Raman spectra.
De-noising and background subtraction is done using a MatLab algorithm 91 which
removes fluorescence on a spectrum-by-spectrum basis.

This procedure utilizes the

46

following approach. First, the noise of the raw spectrum is removed and smoothened using
a medium filter followed by a wavelet function.

Then, the background fluorescence is

removed using two steps of the adaptive minmax method.

8

(a)

7.5
7
6.5
6
5.5
5
600

800

1000

1200

1

1400

1600

1800

1

(b)

0.8
0.6
0.4
0.2
0

600

800

1000

1200

1400

1600

1800

Raman Shift (cm-1)

Figure 3.8 (a) Raw spectrum, where black line shows the adaptive minmax fit (b) Denoised, fluorescence subtracted and normalized spectrum
The first step is to perform constrained and unconstrained polynomial fits using two
different orders. The different orders are determined using F/S ratio, the ratio of maximum
fluorescence to maximum subtracted Raman signal selecting the minimum values of Raman
intensities from the original spectrum for the polynomial fit.

In the second step, this

minmax algorithm will take the maximum values of the fits and remove the background
from the desired spectrum.91
Once the raw spectrum is de-noised and background subtracted, it is normalized by
dividing Raman intensities by the highest Raman peak in the spectrum.

Thus, the final

Raman intensities vary from 0 to 1 as shown in Fig. 3.8 (b). The artifacts of background
subtraction below 600 cm-1 and above 1800 cm-1 can be clearly seen in Fig. 3.8 (b). These
regions are excluded from the analysis as mentioned earlier.
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3.3.3 Diffuse Reflectance Data Collection
Diffuse reflectance and colorimetry measurements were obtained from four areas on
the individual patient; two considered to be healthy tissue and used as a control and two
areas of an acanthosis nigricans lesion on the neck. The two control sites were the inner
forearm approximately 10 cm from the wrist and the flat part of the upper shoulder several
inches from the neck on the clavicle.

Spectra from the acanthosis nigricans lesion were

collected from the median and lateral areas of neck.88

DRS and colorimetry data were

collected from eight patients with acanthosis nigricans over an eight month period. Three
colorimetry and ten DRS absorbance spectra measurements were taken from each site. The
higher number of DRS measurements was necessary due to the smaller area of skin
sampled by the smaller DRS probe area.

Figure 3.9 Left: DRS probe applied to patient’s posterior neck; Right: Colorimeter measuring
patient’s posterior neck88
Since the probing pressure of the human skin can change the diffuse reflectance
spectra, 92 care was taken to insure uniform pressure on the skin over the course of the
study. Figure 3.9 shows how the posterior neck measurements are obtained using the DRS
and the colorimeter.
humidity.

All measurements were taken at the same room temperature and

For documentation and comparison, photographs of the lesion area were also

taken during every visit using a digital camera with a cross-polarized filter.
polarizer was used to remove the specular reflection of the skin surface.

A cross-
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While the colorimetry signal is analyzed purely in terms of the intensity of the
various color components: L*, a*, and b*, the DRS data analysis software models the
physics of the light-skin interaction to calculate biochemical concentrations from the
reflected spectrum. Analysis of the DRS data provides a quantification for the contributing
skin

chromophores,

including

melanin,

oxyhemoglobin,

and

deoxyhemoglobin.

Nevertheless, one can use the intensities of the raw spectral data from DRS ranging from
350-850 mm to characterize the skin condition, and acanthosis nigricans. However, the raw
spectra of the colorimeter were not obtainable.

3.3.4. Diffuse Reflectance Data Processing
To lessen the scatter of the measurements between-patients due to the inherent
differences in skin coloring and composition of the patients, both colorimetry and DRS data
were normalized for every patient prior to analysis. This was done by first calculating the
average of the patient’s forearm control measurements. The scatter of the forearm control
measurements about this average allowed us to characterize the anticipated scatter of the
lesion measurements which was expected to be even greater due to the heterogeneity of
the lesion tissue. All subsequent measurements were then divided by that patient’s average
forearm control to insure that data obtained from the neck control or neck lesion tissue
were really differences from that patient’s normal skin coloring or composition.88

49

CHAPTER 4
STATISTICAL ANALYSIS/CHEMOMETRIC METHODS
The Raman spectra consist of multivariate data.

The intensities are function of

Raman shifts (variables) for a given molecule or a type of tissue.

If a large number of

spectra are collected on a few different unknown samples (such as normal, pre-cursor
lesions, and cancerous tissues) one would like to know how similar to one another these
spectra are, and thus, be able to group them for identifying the samples. Of course, the
identification of a sample based on its spectrum is possible provided some "standard" data
exists for the samples being analyzed.

Thus, when many observed variables (Raman

intensities) seem to describe a particular behavior of an entity, interpreting data using
mean, standard deviation, standard error, etc. is not sufficient and also cannot determine
the variables responsible for that particular behavior of the entity. New method needs to be
developed to find the independent variables which account for most of the variance in the
data and determine the behavior of an entity.

Principal Component Analysis (PCA) and

Discriminant Function Analysis (DFA), chemometric methods provide means to achieve this
purpose and often used in reduction/grouping of Raman spectroscopic data. In this chapter
we briefly describe the principles of these methods which are used in analyzing the data
presented in the thesis.

4.1. Principal Component Analysis
PCA is one of the multivariate methods of analysis and it allows the number of
variables in a multivariate data set to be reduced, while retaining most of the variance
present in the observed variables.

According to this method, the original data set is

transformed into a new data set 93 with a reduced number of orthogonal variables which
carry maximum variance of the original data set. These new variables are called “principal
components” (PC scores or eigenvectors).

The PCs could be then used as predictor or
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criterion variables in subsequent analyses such as DFA. PCA is useful when there is large
data on a large number of variables and it is anticipated that some of the variables are
correlated with one another, possibly because the measurements are on the same entity
(such as a given type of tissue). When the data is plotted against the principal components,
one observes trends in the plot which are basically the independent groups in the data. In
case of biological tissues, the trends in the PCs plots represent pathological conditions of a
diseased tissue where each trend is determined from a unique combination of the original
predictors of the trend or the pathological state. One can obtain these reduced variables in
five steps as follows. For simplicity, let us assume that there are three variables x, y, and z
in our data set.

1. Adjusting the data: Each variable or dimension is subtracted from its mean, i.e., all the
x values are subtracted by the mean of the x ( x ). Thus, the mean of the data set is
zero.

d i  xi  x , where i varies from 1 to n. Here n the total number of data cases

(assume n=6) and similarly we do the same for y and z variables. The mean-subtracted
data which we call “AdjustData” matrix look like;

 x1  x

 x2  x

x3  x
AdjustData  
x  x
 4
 x5  x
x  x
 6

y1  y
y2  y
y3  y
y4  y
y5  y
y6  y

z1  z 

z2  z 

z3  z 
z4  z 

z5  z 
z6  z 

2. Calculating the covariance matrix: For three variables or dimensions, the covariance
matrix is 3x3.
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 cov( x, x) cov( x, y ) cov( x, z ) 


C   cov( y, x) cov( y, y ) cov( y, z )  , where covariance elements are defined as
 cov( z , x) cov( z , y ) cov( z , z ) 


n

cov(a, b) 

 (a
i 1

i

 a )(bi  b)
for n=6.93

(n  1)

3. Calculating the eigenvectors and the eigenvalues of the covariance matrix: By
construction, eigenvectors are unit orthogonal vectors which provide information about
the

trends

in

the

data,

and

thus

characterize

the

data

set.

For

three

variables/dimensions data, there will be three eigenvalues i and the corresponding three
eigenvectors which are determined from the characteristic equation,

| C  I | 0 where I

is the identity matrix. The eigenvectors (EVs) can be calculated by solving the matrix,

CEV  EV with the condition  EVi  1 . These EVs are unit vectors.93
2

i

4. Choosing eigenvectors and forming a feature vector: By ordering the eigenvectors
by the highest to lowest eigenvalue, one can determine the order of significance of these
vectors. The eigenvector with the maximum eigenvalue is the first principle component
of the data set. Feature vector is a matrix vector with the eigenvectors one needs to
keep without losing much information of the data set.

 EV11
FeatureVector   EV12
 EV13

EV21
EV22
EV23

EV31 
EV32 
EV33 

Suppose, the first two eigenvectors are enough to represent the variance in the data
set of three variables/dimensions, then, the feature vector is a 3x2 matrix.
5. Obtaining new data set: First, take the transpose of the two vectors, the feature vector
and the mean-adjusted data vector. Then, the new data set is the multiplication of these
two transposed vectors.
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FinalData  FeatureVector T AdjustData T
Now, the new data are in terms of the chosen eigenvectors with the maximum
information. Note that one can obtain the original data by adding the original mean to the
resulted matrix of the multiplicative of the feature vector and the final data.93

4.2 Discriminant Function Analysis (DFA)
DFA technique classifies the data into independent groups present in the data by
minimizing the variations within the groups and maximizing the variations between the
groups. 94

The groups in our case are the pathological states of the tissue.

In the data

analysis of all my research studies, I have used the output of the PCA as the input to DFA.
The number of discriminant functions generated, are one less than the desired number of
groups in the data set.

The output from the DFA can be used to find the independent

groups in the data.
DFA uses the reverse process of multivariate analysis of variance (MANOVA). 95

In

MANOVA the question asked is whether the groups are significantly different based on a set
of linearly combined discriminant variables. If they are, then the set of linearly combined
discriminant variables can be used to predict group membership. On the other hand, the
DFA is usually concerned with actually putting the data into groups (classification) and
testing how well (or how poorly) data are grouped.

In DFA, first a set of discriminant

functions are calculated and tested for their significance, and then classification is
performed.94 In order to carry out DFA, we assume the data set satisfy certain conditions:


Total number of cases (n) should be greater than the number of variables (p)



Number of groups (g) are greater than 2



A group consists of at least 2 cases (ni ≥ 2 in ith group)



All the discriminating variables are independent and measured at the same interval
level

53



Each group is normally distributed with similar covariance matrix94

4.2.1 Calculating Discriminant Functions
The discriminant function is a linear combination of the discriminating variables
where the coefficients (ui) are determined by satisfying certain conditions which are
explained in section 4.2.1.1.

f km  u 0  u1 x1km  u 2 x 2 km  .......... ....  u p x pkm ---------------------------------------(4.2.1)
Here,

f km is the value of the canonical discriminant function for case m in the group k. x pkm

represents the value of the discriminating variable xi for case m in the group k.

When

calculating the ui for the first discriminant functions, the group mean has to be different as
possible.

The ui for the second discriminant function are determined by maximizing the

group means plus no correlations with the first discriminant function ui’s and so forth.94

4.2.1.1 Scatter of the Data: Within-Group and Between-Groups
Let the total scatter or covariance matrix be T such that tij/(n-1) represent each
element of the T matrix;
nk

g

t ij   ( xikm  xi.. )( x jkm  x j .. ) -----------------------------------------------------(4.2.2)
k 1 m 1

Here, xi.. or xj.. is the total mean of the corresponding variable i or j.

The scatter of the

groups can be measured by the matrix W, where wij/(n-g) represents each element in the
matrix W.
g

nk

wij   ( xikm  xik . )( x jkm  x jk . ) --------------------------------------------------(4.2.3)
k 1 m 1

Here, xik. or xjk. is the mean of the variable i or j of the corresponding group k.
Similarly, the between group scatter is B = T-W, ie. bij  t ij  wij .

These two matrices

54

capture the variances in the data, W and B.
simultaneously by setting

b v
b v

1i i

2i i

b

v

2
i

Thus, by solving the following equations

 1 one can find the coefficients of the DFs.94

   w1i vi

   w2i vi
.
-----------------------------------------------------------------(4.2.4)
.

v    w pi vi

pi i

where λ is the eigenvalue and vi are the set of p coefficients. Thus, ui’s can be find through,
p

u i  vi n  g and u 0   u i xi.. ---------------------------------------------------(4.2.5)
i 1

The largest eigenvalue carries the greatest discrimination.

Thus, the DF1 is the

function with the largest eigenvalue and DF2 carries the second most variances in the data
set, and so forth.

4.2.1.2 Unstandardized Coefficients and Standardized Coefficients
These ui values are unstandardized coefficients as they are calculated using the
original data values.

Unstandardized coefficients make the origin of the discriminant

function axes coincides with the grand centroid (In grand centroid, the discriminating
variables are averaged over all the cases) by incorporating the absolute contribution of a
variable in finding DFs. One can convert these coefficients into standardize coefficients (c’s)
as follows.94

ci  u i

wii
-----------------------------------------------------------------------(4.2.6)
ng

The standardized coefficients provide the relative importance of a variable.
Consequently, we can use these standardized coefficients to find the variables contribution
towards the DFs. i.e. which variable contributes to which discriminant function and how
large the contribution is, and larger the magnitude greater the contribution.
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4.2.1.3 Structure Coefficients
Structure coefficients show the contribution of the each variable in each discriminant
function.

Total structure coefficients can be calculated by taking the product-moment

between a particular variable and the DF. In fact, one can find which variable contributes
the most in each DF.

The structure coefficients vary from -1 to +1.

If the structure

coefficient is close to zero, the DF and that particular variable are hardly correlated. On the
other hand, if the absolute value of the coefficient is close to 1, the variable and the DF are
highly correlated and carry the same information.94
Within a group, if one needs to find the correlation between a DF and a variable,
then within-group structure variables can provide that information.

The within-group

structure coefficients (Sij) can be determined using the following equation.
p

sij  
k 1

wik c kj
wii wkk

---------------------------------------------------------------------(4.2.7)

where Ckj is the standardized canonical discriminant function coefficient for variable k on
function j.

4.2.2. Test of Significance
In order to find the significance of the discriminant functions, relative percentage and
canonical correlation coefficient are taken into consideration.

4.2.2.1 Relative Percentage and Canonical Correlation Coefficient
When there are two or more discriminant functions, by comparing relative
percentages one can find the power of the DFs. Relative percentages can be calculated by
adding all the eigenvalues and then dividing the results into individual eigenvalue.
The canonical correlation coefficients, r* can be calculated from the eigenvalues as
follows.
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ri* 

i
1  i

-------------------------------------------------------------------------(4.2.8)

for ith discriminant function. These canonical correlation coefficients ranging between 0 and
1 provide information about the relationship between groups and discriminant functions.94
A value closer to 1 indicates an existence of strong correlation between the groups and the
discriminant function. If the value is lower the correlation is weaker.

4.2.2.2 Wilk’s Lambda
Without using the discriminant functions, one can find the ability of the variables
which can discriminate the groups through Wilk’s lambda, Λ, which measures the group
differences over the discriminating variables.94
g 1

1
----------------------------------------------------------------------(4.2.9)
i  k 1 1  
i

 

Here, k indicates the number of discriminant functions calculated using the equation 4.2.1.
If Λ equals to one, there are no group differences whereas Λ equals to zero indicates a high
discrimination between groups.

In order to test the significance of Wilk’s lambda, chi-

square or F distributions are used. The formula for chi-square is;



 pg



 2   n  
  1 log e  k
  2  

-------------------------------------------(4.2.10)

The degrees of freedom for chi-square are [(p-k)(g-k-1)].94

4.2.3 Classification of the Data
Classification of the original data into various classes can be performed either using
discriminating variables or discriminant function scores. Similar to discriminant functions,
the classification functions can be calculated for each group as a linear combination of the
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variables.

These classification functions (Gk) are determined to maximize the variance

between the groups and minimize the variance within the groups.

Gk  d k 0  d k 1 X 1  d k 2 X 2  .......... ....  d kp X p --------------------------------------(4.2.11)
Here, Xi can be either the discriminating variables or the DF scores. The coefficients, d’s
can be calculated using the equations below.
p

p

j 1

j 1

d ki  (n  g ) aij X jk and d k 0  0.5 d kj X jk -----------------------------------(4.2.12)
aij are the elements of W-1 matrix. Once the G’s are obtained, then the classification of the
data can be done using the Mahalanobis distance functions.94

4.2.3.1 Mahalanobis Distance Functions
This is a method of calculating the distances of each individual case from its group
centroid. Then, the data are categorized into the closest group. The formula is as follows.
p

p

D 2 ( X | Gk )  (n  g ) aij ( DFi  DFik . )( DF j  DF jk . ) --------------------------(4.1.13)
i 1 j 1

D 2 ( X | Gk ) is the squared distance from a specific case X to the centroid of group k. DFi
represents the DF scores, but one can also use the original discriminating variables, Xi. A
particular case is classified into a group with a smallest D2 value. If the D2 value is high, it
may fit to a different group with similar profile as itself.94

4.3 Other Statistical Methods
The group identification can also be achieved through cluster analysis where a
collection of statistical methods are used to identifies groups of samples that have similar
characteristics. Like discriminant analysis, cluster analysis is also used for data reduction.
In cluster analysis there is no prior knowledge about which elements belong to which
clusters and the clusters are determined through an analysis of the data.

The clustering
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algorithms are broadly classified into two categories: hierarchical and non-hierarchical
algorithms.

4.3.1 Hierarchical Cluster Analysis
Hierarchical cluster analysis (HCA) is a clustering method which utilizes tree diagram
or dendrogram which groups different cases as branches and shows the relationship among
each data case. Typically, all the data in a cluster assumes to have equal belonging to its
cluster. Thus, if a data case has a unique probability to cluster into a certain group then
one has to use alternate methods. 96 There are two approaches for HCA.
agglomerative

(non-hierarchical)

and

divisive

(hierarchical)

They are

procedures. 97

The

agglomerative procedure uses the closest and the far away cases with bottom-up clumping
of clusters, meaning, start with n clusters and merge them to form the others, whereas
divisive approach is a top-down method which forms one cluster and split it to make the
other clusters. It is not necessary to have the same scale for all the independent variables.
Hence, hierarchical cluster analysis is much flexible compared to K-mean cluster (see
section 4.3.2) and initiating the number of clusters is not necessary for this method.
However, the choice of initial cluster centers depends on the case order. Therefore,
one has to perform random orders with different permutations to verify the stability of a
given solution. Thus, this may not be suitable for a dataset with large number of cases.

4.3.2 K-mean Cluster Analysis
K-Mean Cluster Analysis is an non-hierarchical clustering algorithm which produces
disjoint clusters. This technique is suitable for data set which is composed of a number of
distinct classes and it classifies the data using the distances of data cases and the means of
different clusters or k clusters. 98

The number of groups has to be initiated by the user,

which in turn is the number of k clusters. The choice of initial cluster centers depends on
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the case order as in HCA.
number of cases.

Thus, this may not be a good choice for a dataset with large

Also, only variables with similar scales (variables such as years and

money are not in the same scale) can be used to avoid any misleading results. 99

If the

variables are in different scales, either standardizing the data or using an alternate
clustering method such as HCA is necessary.
K-mean cluster method does not calculate the distances between all the cases as in
hierarchical cluster analysis or DFA, thus, it is a fast and efficient method compared to HCA.
When performing a K-mean cluster, each spectrum is assigned to a nearest cluster and then
the means of the classification clusters are updated accordingly.

Finally, the spectra are

grouped into the nearest cluster and the final cluster means represent the average values of
the clustering variables for the spectra grouped into each cluster.

4.3.3 Support Vector Machines
Support vector machines (SVM) are a group of supervised learning methods that can
be applied to classification. These methods are mostly used for pattern recognition. 100 This
is a linear machine learning method which later modified to use kernel methods.

Kernel

method can create possible patterns by using similar features in the data. Thus, a kernel
based learning algorithm consists of two parts, which includes a general purpose learning
machine and a problem specific kernel function. In the general purpose learning portion,
solution is a linear combination of training points with consists of non-negative coefficients.
The latter part is the non-linear mapping on data using kernel functions, the inner products
in some feature space which returns the value of the dot product between the spectra of the
two arguments.

SVM uses the hyperplane/decision surface which is one less number of

dimensions in the data to distinguish two classes by maximizing the margins (minimal
distance to the hyperplane) of the data set. 101
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hyperplane

Figure 4.1 Separation of data using SVM101

As shown in the Fig. 4.1 the distance between hyperplane and the nearest data point
should be large as possible.

Here, the decision function is the hyperplane.

Data in the

decision function and the training algorithm appear only within dot products which is also
called duality, a property of SVM. This duality limitation can be resolved by creating a net
of simple linear classifiers as in neural network or mapping data into a richer feature space,
where, they are linearly separable.
dimensions.

Hence, the kernel functions can utilize infinite

If the dot products are replaced with kernels, one can get a kernel matrix.

Then, this kernel matrix can be used to extract the eigen functions which act as features in
the data.
Unlike PCA, SVM is not an unsupervised method. Thus, SVM needs prior knowledge
of target and many dimensions/variables may complicate the analysis compared to PCA. On
the other hand, too many features may lead to over fitting. One study has observed when
PCA or DFA is combined with SVM the success rate in pattern recognition is near 100%.101

4.3.4 Neural Networks
Neural networks (NNs) are other methods which are useful for classification
problems.

However, for better results of the classification, this method requires a lot of
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training data. The algorithms for NNs utilize radial basis function (RBF) or multilayer
perceptron (MLP) procedures to create a predictive model based on the variables. 102 There
are three major layers; input layer, hidden layer, and the output layer. MLP is the most
popular procedure which consists of multiple hidden layers. 103

Outputs

Hidden

Inputs

Figure 4.2 Structure of neural network

The structure of NN is known as the feedforward architecture (see Fig. 4.2).
Because, the network flows in the forward direction: input layer to the output layer.

No

feedback loops are used. The weights associated with the nodes are repeatedly adjusted by
the training algorithm to minimize the errors and to increase the accuracy of the
predictions. The hidden layer in each procedure (RBF or MLP) predicts the output. Usually,
the hidden unit function is a Gaussian function which consists of three different standard
deviations. 104

In RBF procedure, the network training depends on the number of hidden

layer units, centers and sharpness of the Gaussians.
One of the limitations of NN is that the weights associated with the nodes are
difficult to interpret and also it is unable to identify the process/processes which lead to the
relationship between dependent variables and independent variables.

In such cases, it’s

better to use a different statistical method such as PCA or PLS (see section 4.3.5), etc.
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4.3.5 Partial Least Squares Regression
Partial least squares (PLS) regression is another regression method which can be
utilized when the predictor variables are correlated with each other. 105

This may be the

best alternate to PCA method, when the number of variables is greater than the number of
spectra in a dataset. In fact, the features of PCs and multiple regressions are combined in
PLS. Based on one or more independent variables a model is constructed in PLS, and then
one or more dependent variables are tested using this model.
eigenvalue problem to obtain the eigenvectors in a given dataset.

As in PCA, PLS solves an
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CHAPTER 5
RAMAN SPECTROSCOPIC STUDY OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
Head and neck squamous cell carcinoma is the most common malignancy of the
head and neck region.

This chapter illustrates the results of Raman spectroscopic

investigation of head and neck squamous cell carcinoma of tongue tissues.

5.1 Introduction to Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) represent 9% of the cancers.4
Although there are rapid advances in the fields of therapeutics and diagnostics, the longterm survival of HNSCC patients has not significantly improved in the past 30 years. 106 The
five-year survival in advanced stage cancer is less than 40% and the survival rate for early
stage disease is about 80%.8 Currently the tumor-node-metastasis (TNM) staging is one of
the most important factors clinically used for estimation of survival. It is important to have
reliable estimates for patient survival and it may also impact the treating physician’s choice
of therapy. TNM staging is taken into consideration when recommending treatment options.
Early stage patients are offered single modality treatment such as radiation or surgery,
while multimodality treatment is offered for advanced stage cancer.

As HNSCC is a

heterogeneous disease, TNM staging only provides a rough estimate.8 Not all patients with
the same tumor stage respond in a uniform manner to the available treatment options.

Motivation
Raman spectroscopy has been extensively applied to detect cancers in a wide range
of organs including breast, cervical, 107,

108

skin, 109 and brain 110 tumors. So far, only a few

studies have been performed on HNSCC49, 50 and most of these studies are on frozen tissue
specimens or biopsies. The studies on nasopharyngeal biopsy tissues showed the spectral
features of three Raman bands varied significantly when tissue changed from normal to
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malignant state,49 and another study on frozen tissues from the larynx showed that the
characteristic Raman spectral features for normal, carcinoma, and papilloma tissues are
different.50
In this exploratory study, our primary objective was to investigate the formalin fixed
deparaffinized tissues of invasive SCC, normal, and carcinoma in situ of tongue.

The

purpose of this study was to investigate: (i) whether Raman spectroscopy when combined
with chemometric methods could become a potential diagnostic tool to detect HNSCC in its
early stages, and (ii) whether there are reproducible and identifiable HNSCC-specific
biomarkers in the Raman spectra.

5.2 Materials and Methods
5.2.1 Sample Preparation
In this exploratory study, we have investigated a total of 17 formalin-fixed
deparaffinized tissues from 17 different patients, of which 7 were normal, 4 with carcinoma
in situ, and 6 with invasive squamous cell carcinoma. The tissue blocks were processed at
the University Pathology Research Services, Karmanos Cancer Center. The samples were
prepared as described in Chapter 3.

The images were taken from the tissue sections to

ensure that the Raman spectra were collected from the same regions on the unstained
tissue sections as the ones marked by the pathologists on the stained sections. Standard
tissue processing methods were used to process the tissues and to remove the wax from
them.

5.2.2 Pathological Examination
The

H&E stained

sections

were

examined

separately

by

three

experienced

pathologists from Detroit Medical Center, Detroit, MI who marked normal, carcinoma in situ,
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and invasive SCC regions on every H&E stained slide. In all the tissue samples used in our
study, there was no discrepancy in the evaluations by the three pathologists.

5.2.3 Raman Spectroscopic Measurement
For this study, a Jobin-Yvon Horiba Triax 550 Raman spectrometer system with an
argon-ion laser (514.5 nm) was used record the spectra (see Chapter 3). The spectral
resolution of the Raman spectrometer was about 4 cm-1 and the laser power at the spot was
6 mW. The spectrometer was calibrated using the known peak from silicon. The Raman
spectra were collected in backscattering configuration with a 100x long working distance
(3.4 mm) objective with a numerical aperture of 0.8 (spot size ~ 1 µm diameter).

To

improve signal to noise ratio, spectra were recorded using 40 second integration time and
averaged over 5 accumulations. Each spectrum was collected from a new location on the
tissue.

5.2.5 Raman Data Processing
For statistical analysis, we considered Raman data from 550–1800 cm-1 which
contains fundamental vibrations of the biomolecules providing information about their
molecular structure and conformation.

The Raman spectra often contain fluorescence

background emanating from the aromatic chromophores and other noise.

The data were

preprocessed for reducing the noise using adaptive minmax/wavelets method91 and then
normalized with respect to the peak with highest Raman intensity in the spectrum. In order
to obtain a reliable statistical analysis, approximately 130 spectra from each category
(totaling 401 Raman spectra) from 17 different tissue specimens were recorded.
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Figure 5.1 Mean Raman spectra of (a) normal, (b) carcinoma in situ, and (c) invasive SCC.
The three images on the right represent corresponding pathology images. Circle marks
represent the approximate locations where the spectra were taken (images are taken from
20) 111
Figure 5.1 shows the mean Raman spectra of the normal, carcinoma in situ, and
invasive SCC tissues along with their corresponding pathology images (right panels). The
marked circles indicate the representative regions from where the Raman spectra were
collected.

The Raman shifts of some of the bands whose intensities change when tissue

changes from normal to invasive SCC are also marked in the spectra.
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Figure 5.2 PCA plots for full spectrum analysis (a) PC 2 vs. PC 1, (b) PC 3 vs. PC 1111
A total of 544 Raman intensities separated by 2 cm-1 intervals from the 600-1716
cm-1 spectral region (lower and upper edges of the measurement range were discarded to
minimize any artifacts due to background subtraction) were used as statistical variables.
PCA was performed on the whole data to reduce the number of original variables to fewer
independent variables.

The initial 544 intensity variables were reduced to 16 variables

[principal components (PCs)] which captured 98.2% of the variance in the Raman data.111
The first three PCs contained the maximum variance of the Raman data and when
plotted against each other, one can see two trends (Fig. 5.2) due to the normal and the
invasive SCC data. These PCs were used as input variables for the DFA to classify the data
into the three pre-assigned groups. This is achieved by maximizing the variance between
the groups while minimizing the variance within the groups. Figure 5.3 shows the groupings
in a plot of discriminant functions (DFs).

Most of the data are very well separated into

distinct groups representing normal, carcinoma in situ, and invasive carcinoma.
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5.3 Results
The Raman spectra of tissue samples are quite complex as the tissues contain a
diverse set of small and large biomolecules. The observed spectral intensity variations and
frequency shifts shown in Fig. 5.1 are due to molecular compositional and conformational
differences in the tissues. The vibrational frequencies associated with different functional
groups and backbone chains, for example, in proteins, saccharides and nucleic acids,42 often
overlap, thus making it difficult to assign a specific observed band in the Raman spectrum
to a specific functional group of a particular molecule in the tissue.

Thus, the frequency

assignments have varied significantly among different published studies in the literature.
Nevertheless, some functional groups associated with specific molecules often give rise to
relatively narrow and well resolved bands in the Raman spectra. These bands can provide
direct information about the biochemical composition of the tissue and can be used to study
the changes that occur due to the onset of cancer.

5.3.1 Chemometric Analysis of the Raman Spectra
The physical significance of the variations in the band intensities can be understood
through chemometric analysis methods which correlate the spectral differences with the
pathological variations in tissues and thus help in interpreting the spectral differences in
terms of changes in biochemical composition.

The classification predictions based on

Raman spectroscopy measurements performed by a leave-one-out validation test were
cross-validated with the "gold standard" results of pathology. The comparison of the two
outcomes is given in the cross-validation table (Fig. 5.3). From the data presented in Fig.
5.3, it is encouraging to note that Raman spectroscopy can detect HNSCC about 89% of the
time in the tissues we have studied; with 91% accuracy in carcinoma in situ and normal
tissues.
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Classification: cross-validated data (%)
Invasive
Group
Normal
In situ
SCC
Normal

91.4

7.9

0.7

In situ

4.5

90.9

4.5

Invasive SCC

2.6

8.6

88.8

Figure 5.3 DF plot for the analysis using full spectrum, and the corresponding classification
results. Ellipse (blue), star (green), and cross (red) symbols represent normal, carcinoma in
situ, and invasive SCC, respectively111
Biomarkers play very critical role in drug development and treatment as they are the
indicators of the normal and cancerous physiologies of an organ. Raman spectroscopy has
the potential to determine the biomarkers of a disease. In this exploratory study, we have
attempted to determine the Raman bands which play a significant role in differentiating the
pathological states of tissue by performing statistical analysis using 12 Raman bands that
show largest variation in their intensity (marked on Fig. 5.4).

For another DFA, we

calculated the sum of the intensities under these bands and used these sums as the input
variables for the calculation.
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Figure 5.4 DF plot for the analysis using 12 selected Raman bands (shown on the Raman
spectra), and the corresponding classification results. Ellipse (blue), star (green), and cross
(red) symbols represent normal, carcinoma in situ, and invasive SCC, respectively111
Figure 5.4 shows the DFA plot representing normal, carcinoma in situ, and invasive
SCC states of the tissues as well as the cross-validated classification results using leaveone-out method. It is interesting to compare these results with the full spectrum analysis
as done in Fig. 5.3.

Comparison of these results with full data (544 intensity variables)

shows that these 12 Raman bands are quite successful in classifying the data.

The

classification table shows that 86% of the original carcinoma in situ tissue samples and 85%
of the invasive carcinoma tissue samples are correctly classified, whereas the normal tissue
sample accuracy was only reduced by 2%. The prediction accuracy only decreased by 4%
compared with the whole spectrum analysis (Fig. 5.3), indicating that this set of 12 Raman
bands carry sufficient biochemical information of a tissue to accurately predict its
pathological state.111
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5.3.2 Signatures of Tryptophan and Keratin in Invasive SCC of Tongue
We have investigated the biochemical origin of these 12 prominent Raman bands
whose intensities change noticeably when tissue changes from normal to invasive SCC.
Interestingly, we can assign these bands to specific amino acid residues and a particular
class of proteins.

Figure 5.5 Upper panel: The mean Raman spectra for normal (solid blue line), carcinoma in
situ (dotted green line), and invasive SCC (dashed red line), lower panel: Raman spectra of
keratin and L-tryptophan111
In Fig. 5.5, we show the Raman spectra of normal, carcinoma in situ, and tumor
tissues along with the spectra of keratin (of human white hair) and L-tryptophan (SigmaAldrich).
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Raman Shift

Peak Assignment

(cm-1)
640

C-C stretching and twisting of proteins-Tyrosine

664

Ring breathing mode in the DNA bases

718

C-N nucleotide peak or lipid/DNA

753

Symmetric breathing of tryptophan

780

DNA/uracil ring breathing mode

824

Tyrosine, phosphodiester

850

Amino acids, keratin

933

Tryptophan or single bond stretching vibration for amino acids or C-C
stretching
C-C stretch, collagen backbone, α-helix, , keratin

1000

Phenylalanine

1028

Phenylalanine

1080

Typical phospholipids, phosphodiester groups in nucleic acids/collagen

1097

Nucleic acid PO-2 or C-N stretch

1124

Lipid or C-N and C-C stretch, proteins, lipids

1152

C-N stretch, proteins

1167

C=C stretch lipids

1230

Tryptophan

1235

Amide III, keratin

1240

Amide III, RNA , keratin

1306

Lipid/protein, keratin

1335

CH3/CH2 wagging (collagen, nucleic acids), tryptophan, keratin

1366

Tryptophan or phospholipid (CH3)

1390

CH-rocking

1420

COO- symmetric stretch, CH2 wag, bend, Tryptophan

1446

CH2 bending mode of proteins & lipids, keratin

1562

Tryptophan

1584

Tryptophan, phenylalanine

1614

Tryptophan

1650

Amide I, C=C stretch, keratin

872

Table 5.1 Raman peaks assignment for the observed bands.42, 112, 113, 114, 115, 116, 117 The
Raman shifts written in bold face show a significant variation in intensity depending on the
pathological state of the tissue
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The Raman bands at 753, 1365, 1562, 1584, and 1614 cm-1 which show increase in
their intensities in invasive SCC tissue can be assigned to L-tryptophan. While the bands at
850, 933, 1235/1240, 1306, 1335, 1446, and 1650 cm-1 which show decrease in their
intensities can be attributed to keratin. 118

A strong correlation between peaks associated

with tryptophan and keratin is seen from their Pearson correlation coefficient values (shown
in Table A1 in the Appendix A).

Thus, our chemometric analysis strongly suggests that

enhancement of tryptophan and down-regulation of keratin may be linked to the
progression of SCC of tongue.
It is interesting to note that a recent study by Tankiewicz et al 119 has shown an
enhancement in the concentration of tryptophan and its derivatives (anthralinic and
kynurenic acids) in oral tongue squamous cell carcinoma leading to a proposition that
tryptophan may be a factor responsible for the development of cancer. An earlier study by
Crowe et al showed a down-regulation of keratin K19 in squamous cell carcinoma cell lines
in oral cavity 120 and in another study by Balm et al showed the absence of cytokeratin-18 in
66% of the carcinoma of oral cavity. 121

Our assignment of changes in Raman band

intensities to L-tryptophan and keratin are consistent with the above studies. However, it
should be noted that the Raman bands of the pure L-tryptophan are much sharper and the
1420 cm-1 peak appears to be absent or shifted in the spectra of the tissues.
The peak broadening in complex systems such as proteins and inhomogeneous
system like a tissue compared to pure monomer is expected to occur due to interaction
effects. In amino acids and small oligo-peptides and other molecules, the 1420 cm-1 Raman
band is assigned to mixed vibrational mode consisting of symmetric COO- stretching, CH2
wagging and bending vibrations.

Thus, it is possible that the 1420 cm-1 is absent in the

spectra of tissues because it arises from the symmetric stretching of COO- group of free
amino acid112-105. In tryptophan, the Raman band ~1420 cm-1 is assigned to one of the wellknown vibrational modes of the indole ring.115-118

However, as expected, the energy of this
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mode changes when present in other medium due to its interaction with the medium’s
components, e.g., in aqueous solution it shifts107 to ~1440 cm-1. Thus, it is possible that,
when L-tryptophan is present in tissue’s environment, this mode is either strongly damped
or blue-shifted and buried under the intense band structure at 1446 cm-1.

5.3.3 Monitoring the Progression of SCC with Raman Spectroscopy
It is interesting to note that as normal tissue transforms into carcinoma in situ,
changes in the intensities of bands at 753, 850, 933, 1235, 1240, 1306, 1335, 1365, 1446,
1562, 1584,1614, and 1650 cm-1 are quite significant. These spectral changes are caused
by the changes in the biochemical composition of tissues upon normal tissues turning into
carcinoma in situ. Table 5.1 lists all the observed Raman frequencies along with possible
assignments. The frequencies of the peaks that change intensity depending on the state of
the tissue are shown in bold in Table 5.1.

Further, changes in intensities occur when a

carcinoma in situ tissue turns into SCC, and thus Raman spectroscopy can distinguish
carcinoma in situ from normal tissues.

5.4 Discussion
Of the available prognostic factors in HNSCC such as TNM stage, surgical margin
status,

extra-capsular

spread,

angiolymphatic invasion. 122,

123

number

of

positive

lymph

nodes,

perineural

and

TNM staging is currently the most often used clinically. It

helps in selecting the aggressiveness of postoperative adjuvant therapy (radiation alone
versus chemoradiation). To maximize treatment effectiveness and minimize toxicity, it is
important to have reliable survival estimates.

Unfortunately, TNM staging provides an

estimation of overall survival and is not always correct in predicting treatment response in
individual patients.
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In this study, we have used Raman spectroscopy which uses characteristic Raman
spectral features rather than morphological features to determine the pathological state of
tongue squamous cell tissues. It is an objective technique which eliminates inter-observer
variability and requires short time (a few minutes) to measure the spectrum of a tissue. In
this study, we have identified the spectral features of normal, carcinoma in situ, and
invasive SCC tissues of tongue that can discriminate between these three tissue types. We
have analyzed the Raman spectral data using PCA93 and DFA94 chemometric methods. PCA
found two distinct trends in the data while DFA was able to group the data into three
distinct groups.

The classification results were further tested by leave-one-out cross-

validation method and compared with the "gold standard" of pathology which clearly
predicted the normal, carcinoma in situ, and invasive SCC with high accuracy.
We found that the intensities of the Raman bands assignable to tryptophan (753,
1365, 1562, 1584 and, 1614 cm-1) increase while those attributable to protein keratin (850,
933, 1235/1240, 1306, 1335, 1446, and 1650 cm-1) decrease when tissue changes from
normal to carcinoma in situ and then to invasive SCC. This suggests that tryptophan and
keratin play an important role in SCC of tongue.111

12 Raman bands
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Figure 5.6 ROC curves calculated from the analysis (from left to right) of; full spectra
analysis and 12 Raman bands111
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Based on the discriminant function 1 calculated from the whole data and 12 Raman
bands, Receiver Operating Characteristic (ROC) curves (Fig. 5.6) were determined. 124 They
are sensitivity vs 1- specificity plots. Sensitivity, calculated from the ratio of carcinoma data
to the total data, represents the true positives of a test (for example, in our study it is
carcinoma). And 1- specificity describes the false positives of a test (normal but identified
as carcinoma) as a ratio of normal to the total data. In the perfect scenario, ROC curve is a
step function. If the area is close to 1, then the test result is considered perfect whereas
area close to 0.5 is considered bad.

In our case, the area under the curve for whole

spectrum and analysis using 12 Raman peaks are 0.97 and 0.959. Thus, the capability of
differentiation between invasive squamous cell carcinoma and normal using Raman
spectroscopy is quite remarkable even with twelve selective Raman peaks that exhibit
intensity variations.

5.5 Conclusions
Raman spectroscopy is an optical technique capable of providing molecular level
information, enabling investigation of functional groups and molecular conformations.
Molecule-specific spectral bands can provide direct information about the biochemical
composition in a tissue thus allowing one to detect small changes in biochemical
compositions which occurs at the inception of cancer.

We were able to detect with 91%

success rate the normal and carcinoma in situ tissues of tongue and with 89% accuracy the
invasive squamous cell carcinoma tissues. Thus, this exploratory study shows that Raman
spectroscopy can be used in studying the head and neck squamous cell carcinoma.

Our

study shows increased levels of tryptophan and decreased levels of keratin as the tissue
changes from normal to squamous cell carcinoma which is consistent with other biochemical
investigations.119-121
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CHAPTER 6
RAMAN SPECTROSCOPIC STUDY OF PROSTATIC INTRAEPITHELIAL NEOPLASIA
Prostatic intraepithelial neoplasia is the precursor lesion of prostate cancer. If this
pathological state can be optically identified from different grades of cancer, then, this could
lead to the screening of potential prostate cancer patients in vivo or in vitro using Raman
spectroscopy. In this chapter, we have attempted to explore this possibility using Raman
spectroscopy.

6.1 Introduction to Prostate Cancer
Prostate cancer is the second most common cancer among men worldwide based on
the statistical data collected through 2008.1 Ever since screening with the Prostate Specific
Antigen (PSA) test began, which measures the level of PSA in patients’ blood, its mortality
rate has trended downwards due to its early detection and treatment. 125,

126

Other

detection method involves a digital rectal examination to check for growths in or
enlargement of the prostate gland in men. If there is a tumor growth in the prostate, it can
often be felt as a hard lump. To further confirm the tumor, a pathological examination is
performed on biopsies of the prostate and the initial grade of the cancer is given by the
pathologist.15 According to the current policy, the age limit to obtain PSA has been lowered
to 40 years.

In addition, a decision to perform biopsies is not followed by PSA and DRE

alone, other factors such as patient age, PSA velocity, PSA density, family history, ethnicity,
etc. are also considered. 127 One of the common tissue extraction methods is needle biopsy.

Motivation
Detection and confirmation of prostate cancer is very crucial for its successful
treatment in order to improve survival rate. Sometimes the standard screening programs
can provide misleading results leading to wrong or over-treatments and occasionally to fatal
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consequences. The interpretations of histological examination of biopsies, considered as the
“gold standard” for diagnosis, are often subjective and can vary significantly from one
pathologist to another. 128 Hence, it is imperative to detect the state of the disease with a
method which is objective and capable of providing results within a very short period of
time, in 1-2 minutes. Raman spectroscopy techniques are very well suited for these types
of goals and, in addition, they are also capable of probing disease at cellular level.

This

optical method can provide information about the changes in the concentrations of the
constituent biomolecules of tissues and detect the progression or state of the disease.
Therefore, this technique can be used to diagnose pathological condition of organs and
progression of disease.
Apart from benign epithelia (BE), PIN, or cancerous micro acinar clusters, stromal
cells also surround these biomolecular patterns. The interaction between human prostatic
stroma and the epithelial cells in normal prostate is somewhat different from the stromal
cells in prostate tumors. 129

The normal human prostatic stroma which consists of

fibromuscular matrix enclosing the prostatic ducts limits the proliferation of the epithelia
unlike the stromal cells in the prostatic tumors, which contains fibroblasts or myofibroblasts.
The stroma bordering prostatic tumors is called “reactive stroma” or “carcinoma associated
fibroblasts”.129 It is imperative to explore the spectral features of the stromal cells in benign
epithelia (BE), PIN, and tumor stages and understand its linkage with cancer and its
progression. It appears that the reactive stroma in prostate initiates the carcinogenesis and
helps its progression. 130,

131, 132

Our primary goal is to investigate luminal cells of PIN and

compare their spectral features with BE and cancerous cells of the prostate tissues. It is
important to compare luminal cells alone of each pathological category since basal cells are
absent in the epithelium of microacinar structures of the prostate cancer. Our secondary
goal is to examine the Raman spectral features of the stroma surrounding BE, PIN, and
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cancer in deparaffinized tissues.

To the best of our knowledge, our exploratory Raman

study is the first report of such an investigation.

6.2 Materials and Methods
6.2.1 Raman Spectroscopy
As in the pediatric tumor study, we used a Renishaw RM1000 Raman microscopespectrometer with a 785 nm diode laser excitation source.

Each Raman spectrum was

averaged over three scans with 20 second integration time to gain a good signal-to-noise
ratio.

The scattered light was collected through back scattering geometry and dispersed

through a 1200 lines/mm grating structure before being sent to the CCD detector.

6.2.2 Preparation of Tissues for Raman Spectroscopy
Tissue specimens which were embedded in paraffin wax were obtained from
Karmanos Cancer Center and Harper University Hospital in Detroit, MI, and were processed
at the University Pathology Services at Karmanos Cancer Center.

In this study, we

particularly selected those tissue specimens that were purely either BE, PIN, or cancerous.
For each specimen, two parallel sections were cut. One 5 μm in thickness (H&E stained)
was used for pathological examination and the second 10 μm adjacent thick section was
used for Raman spectroscopic measurements.

These H&E slides were reviewed by three

experienced pathologists and none of the cases were found to be in dispute.

Standard

procedure was used to remove paraffin wax from the 10 μm thick tissue specimens before
they were used for Raman study.

The wax in the tissue layers was removed by using

xylene and ethanol baths. However, if this was not done properly, the wax residues would
likely interfere with the Raman spectrum in the Raman bands at 1063, 1130, 1296, 1436,
and 1465 cm-1. In our samples, we did not observe any of these sharp wax bands. It is
assumed that the morphological features do not change across the few micrometer thick
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layers, hence the H&E stained layer can be used as a guide layer to collect Raman spectra
from the specific sites of the adjacent unstained deparaffinized tissue section.

6.2.3 Raman Spectroscopic Measurements
A total of 34 tissue specimens obtained from 33 patients were used in this study.
Out of these, 12 specimens were benign, 11 were PIN, and 11 with cancer. Images were
taken from the marked regions corresponding with each H&E slide to insure that the data
were taken from the correct regions of interest. When collecting Raman spectra, the laser
beam was focused only on the luminal cells.

The circular regions in Fig. 6.1 show the

regions from where the Raman spectra were collected. In addition, each data location was
imaged to make sure that each Raman spectrum is taken from a new luminal cell of the
target tissue.
The Raman spectra were collected in the 500-1900 cm-1 range as the region of 6001800 cm-1 is commonly known as the “biological window” in the field of biomedical research.
Most of the biomolecules show intense Raman excitations across the biological window. The
extra 100 cm-1 were recorded in both ends of the Raman spectra to avoid any artifacts
which may occur while removing the fluorescence background from each spectrum. A total
of 1220 Raman spectra were collected from the tissue samples in which 207, 202, and 208
were from BE, PIN, and cancer, respectively. We have collected roughly the same number
of spectra from each category so that the variations in the spectral features of BE, PIN, and
cancer can be reliably compared. In addition, 201 Raman spectra were obtained from the
stromal areas surrounding the BE, PIN, and cancer (Gleason grade 6). Here, the Raman
measurements of stromal cells in cancer tissues were obtained from the bordering of the
micro acinar clusters as shown in Fig. 6.1.
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Figure 6.1 Pathology pictures of (a) BE, (b) PIN, and (c) Cancer (images are taken with 40x
magnification). Elliptical symbols represent locations of the Raman measurements 133
6.2.4 Raman Data Processing and Chemometric Analysis
While collecting Raman spectra, we made sure that there was no non-standard noise
in any spectrum and, if found, we discarded those spectra from our database.

The

remaining spectra were cleaned from any spurious bands due to cosmic event and noise by
using wavelets method.91 The fluorescence background from each spectrum was removed
with a minmax adaptive algorithm that requires no a priori knowledge of the spectra.
Finally, each spectrum was normalized with respect to the highest intensity value of the
spectrum.
Multivariate/chemometric statistical method, like PCA93 which determines correlation
in the variance, can be used to detect trends in the data set and data can be further
analyzed using DFA94 to find classes of the data.

First, we analyzed the data using PCA

which reduced the dimensionality of the original data set from 601 variables to 19 new
variables, called the eigenvectors. These new variables captured 97% of the variance of the
data.

Examination of the first two eigenvectors showed distinct trends in the data

representing BE, PIN, and cancer. These new fewer variables carrying most of the variance
of the data are useful for determination of the groups in the data. To find classes in the
data, we have performed DFA94 using the 19 eigenvectors as the input variables.

The

classification of each pathological state was done using the leave-one-out method, where
each data case is considered a new case and compared with the rest of the data pool.
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6.3 Results and Discussion
The average Raman spectral features of BE, PIN, and cancer are shown in Fig. 6.2.
We found changes in the peak intensities of most of the Raman bands (Raman band
assignments are listed in Table 6.1) of the PIN spectrum. These changes are fundamentally
related to the changes in the concentrations of the biochemicals of BE and normal luminal
cells. Significant changes were found in the region from 600 cm-1 to 1145 cm-1 which are
shown in the lower panel of the Fig. 6.2.

Figure 6.2 Average Raman spectra of BE (Blue dash line), PIN (green), and cancer (red
dotted line). The lower panel shows the Raman spectral range of 600-1145 cm-1 133
Some of the changes are noteworthy: the band at 726 cm-1 (assigned to ring
breathing mode of DNA/RNA bases) becomes quite intense in PIN, and in addition the
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Raman bands at 853, 931 cm-1 ((C-C) stretching mode of proline, valine, and protein), 960
cm-1, and 1090 cm-1 (symmetric phosphate stretching vibrations) also showed increases in
their intensities when the pathological state of the cell changes from BE to PIN, while the
bands at 1605 cm-1 and 1667 cm-1 (amide I) showed suppression in their intensities. When
comparing the average spectral changes of PIN with cancer, we found that the peak
intensities at 780 cm-1, 1240 cm-1 (proline, tyrosine), 1330 cm-1, and 1605 cm-1 are
enhanced when the pathological state of luminal cells changes from PIN to cancer, while the
bands at 726, 853, 931, 960, and 1090 cm-1 showed a decrease in their intensities which
also showed a similar trend like the bands of BE.

Raman
Shift (cm-1)
726
758
780
829

Peak Assignment

1081

A ring breathing mode of DNA/RNA bases
Symmetric breathing of tryptophan
DNA/uracil ring breathing mode
Tyrosine, phosphodiester, O-P-O stretching DNA/RNA
Ring breathing mode of tyrosine, C-C stretch of proline
ring, glycogen
Tryptophan, hydroxyproline, C-O-C ring
C-C stretch, α-helix, protein band
Cholesterol, phosphate of HA
Phenylalanine
Phenylalanine, proline
Typical phospholipids, phosphodiester groups in nucleic
acids/collagen

1090
1240
1313

Symmetric phosphate stretching vibrations
RNA, Amide III, collagen
Lipid/protein

1330

Collagen, nucleic acids & phospholipids
CH2 bending mode of proteins & lipids, methylene
deformation
Tryptophan, tyrosine
Cytosine, phenylalanine, tyrosine, C=C
Protein, C=C stretch, amide I

853
878
931
960
1004
1032

1450
1557
1605
1667

Table 6.1 Raman peak assignment41, 42
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The Raman bands at 780 and 878 cm-1 showed progressive increase in their
intensities when cells change from BE to PIN and then to cancer indicating that the increase
in the concentrations of the biochemicals related to these bands is continuous.

These

Raman bands should be further investigated and if found to show the same trend, then they
can be used as diagnostic variables for the detection and progression of prostate cancer.

6.3.1 Chemometric Analysis of the PIN, BE and, Cancer
The first three eigenvectors or the principal scores (PCs) are plotted against each
other in Fig. 6.3. The left panel is the plot of PC2 vs. PC1 and the right panel represents
PC3 vs. PC1. These three principal scores contain 76% of the variance in the data showing
different trends for each pathological state.

Although some of the data seem to be

overlapping with each other, the different trends are still very clear in the data.

Largest

variance in the data was captured by the PC1 which is shown by the spread of the BE, PIN
and cancer data along the PC1 axis. PC3 shows a distinct trend present in the PIN spectral
data.

Figure 6.3 PCA results of BE, PIN, and cancer. PC2 vs PC1 is on the left panel and the PC3
vs. PC1 is on to the right133
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Figure 6.4 DF plot of BE, PIN, and cancer133

The average spectra of BE, PIN, and cancer showed distinct variations in the
intensities of certain peaks while the spectral features of the individual spectra of each
category are expected to be scattered about its average value and must also be different
from other categories. As tissue changes from BE to PIN and then to cancer, the spectral
variances in the data must exhibit some distinct classes if each of these categories is
pathologically different.

The classification results are shown in Fig. 6.4 where we clearly

observed three distinct classes with their centroids (marked with black squares) far away
from each other. It is interesting to note that the PIN class was a very distinct class from
other classes and doesn’t have much overlap with others. There are only three pathological
states, which means, there are only two discriminant functions. The discriminant function 1
shows the maximum variance in the Raman data and the discriminant function 2 contains
the rest of the variance.94 The x-axis shows a continuous change from BE to PIN and then
to cancer. The group prediction of the Raman spectroscopy data using DFA was compared
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with that of pathological diagnosis, the gold standard for diagnosing cancer.

To test the

validity of our predicted classifications, we have performed a leave-one-out cross-validation
where the group classification for each spectrum with one of the known pathological states
is determined while using the remaining data as a training set.

The results of cross-

validation were compared with the classification results in Table 6.2. We found that the PIN
could be predicted with 82% accuracy while the prediction accuracies for BE and cancer
were 76% and 91 %, respectively.

Predicted Group Membership
Crossvalidated

Count

%

Group

BE

PIN

Cancer

Total

BE

158

20

29

207

PIN

33

165

4

202

Cancer

16

2

190

208

BE

76.3

9.7

14.0

100.0

PIN

16.3

81.7

2.0

100.0

7.7

1.0

91.3

100.0

Cancer

Table 6.2 Classification results of BE, PIN, and cancer133

6.3.2 Stroma-Epithelium Raman Spectra Comparison
It is interesting to study the stroma around each pathological state as it could
provide useful information about the onset of cancer. The nature of stroma observed was
found to depend on its environment.129

Figure 6.5 shows the average Raman spectra of

stroma surrounding BE, PIN, and cancer together with the average Raman spectra of the
relevant epithelium in black.
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Figure 6.5 Average Raman spectra of stroma in BE, stroma in PIN, and stroma in cancer
together with the epithelial cells of BE, PIN, and cancer, respectively which represent in
black dotted format133
Most of the Raman bands show significant differences between PIN and stroma
associated with it, especially the Raman bands at 726, 780, 853, 931, 960, 1081, 1313,
1330, 1605, and 1667 cm-1. The Raman bands associated with DNA/RNA (726, 780, 829,
and 1330 cm-1) are suppressed in all the stromal Raman spectra compared to the luminal
cells

of

BE,

PIN,

and

cancer.

In

fact,

the

Raman

bands

incorporating

amino

acids/protein/collagen (853, 931, 960, and 1240 cm-1) were significantly enhanced. The
Raman band at 1081 cm-1 which is related to phospholipids was also enhanced in stroma.
These observations are in full agreement with the actual biochemical composition of stroma.
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The chemometric analysis was performed on the stromal data.

Similar to the

epithelia investigation, the PCA created 15 principal scores containing 98% of the variance
in the Raman data.

Apparently, the three categories: stroma in BE, stroma in PIN, and

stroma in cancer are quite distinct as shown in the DF plot together with the overlapping
average Raman spectra of stroma in BE, stroma in PIN, and stroma in cancer (see Fig. 6.6).

Figure 6.6 DF plot of stroma surrounding BE, PIN, and Cancer. The average Raman spectra
of stromal data for each category are shown to the right of the figure133
Table 6.3 shows the predicted group membership using a leave-one out classification
method for stromal investigation.

We found that the stroma surrounding PIN could be

correctly identified with 83.6% accuracy. The stroma in BE and cancer were classified with
81.6% and 87.1% accuracy, respectively.
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Predicted Group Membership
Group
Crossvalidated

Count

%

Stroma- StromaBE
PIN

StromaCancer

Total

Stroma-BE

164

3

34

201

Stroma-PIN

14

168

19

201

Stroma-Cancer

18

8

175

201

Stroma-BE

81.6

1.5

16.9

100.0

Stroma-PIN

7.0

83.6

9.5

100.0

Stroma-Cancer

9.0

4.0

87.1

100.0

Table 6.3 Classification results of stroma in BE, PIN, and cancer133

It seems that when comparing stroma enclosing PIN with stroma in cancer, the
Raman bands at 853, 931, 1240, and 1330 cm-1 were increased while the Raman bands at
1081 cm-1 and 1450 cm-1 were decreased. In fact, the stroma associated with PIN showed
less interference with the changes occurring in the PIN structure whereas the stroma
associated with cancer interfered more with the progression of the cancer epithelia as the
Raman bands at 1313, 1330, and 1450 cm-1 are relatively the same as in cancer and stroma
around it. Thus, the stroma associated with BE, PIN, and cancer can be detected with high
accuracy using Raman spectroscopy.
When spectral data of all the pathologies are combined and analyzed statistically to
find their distinct classes, interestingly we found a clear separation of stroma from BE, PIN,
and cancer.

In addition, stroma-BE, stroma-PIN and stroma-cancer were also well

separated as shown in Fig. 6.7. Note that DFA constructs one less number of discriminant
functions than the number of user-defined categories.

Thus, this analysis produces 5

discriminant functions due to 6 categories. Figure 6.7 only shows the first two discriminant
functions which carry 89% of the information in the Raman spectra. Hence, the overlapping
of data in this 2-D plot may not be the same for the other dimensions.
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Figure 6.7 DF plot of all the categories: BE, PIN, cancer, and stroma surrounding BE, PIN,
and cancer133
The results clearly show that as a luminal cell changes from its normal state to PIN
before becoming cancerous, the Raman spectral features have already changed and these
changes continue as the disease progresses. Moreover, if the laser beam is shined only on
the stromal regions far away from its corresponding pathologies (PIN, BE, and cancer), we
expect the Raman spectral features to be very different and capable of identifying itself with
much higher accuracy.
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Figure 6.8 ROC curves for PIN vs cancer (left) and stromal PIN vs stromal cancer (right)133

We also constructed Receiver Operating Characteristic (ROC) curves114 for both the
analyses, PIN compared to cancer and stromal comparison between stroma around PIN and
stroma associated with cancer as shown in Fig. 6.8.

This ROC curve is a graph where

sensitivity and 1-specificity are plotted against each other. Sensitivity is the ratio of true
positives (cancer measurements which are correctly identified as cancer) over the total PIN
data and specificity is the ratio of true negatives (PIN measurements which are correctly
identified as PIN) over the total PIN data.

The sensitivity and specificity for luminal cell

investigation of PIN and cancer are 98% and 99%.

For the stromal investigation, the

sensitivity and specificity are about 90% and 94%, respectively. The area under the curves
(AUC) infers the validity of the test. As shown in Fig. 6.8, both the AUC’s are more than
0.96 indicating a very good test for PIN and stromal investigation.133

6.4 Conclusions
In this study, we investigated using Raman spectroscopy on luminal cells from
tissues which are purely either BE, PIN, or cancerous. We particularly focused on PIN and
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compared its spectral features with BE and cancer. As tissue transforms into PIN, most of
the Raman bands of BE showed changes in their intensities and, in addition, an intense
Raman band at 780 cm-1 (assigned to DNA/RNA) also appeared in PIN’s spectrum.

As

luminal cells become cancerous, some of the Raman bands including 780 cm-1 showed
progressive increase in their intensities. Additionally we also studied stromal cells around
each pathological state; BE, PIN, or cancer. Chemometric analysis of the data shows that
the spectral variations in the data are quite pronounced and can be easily classified with
very high accuracies into distinct pathological groups.

The sensitivity and specificity of

luminal cells of PIN and cancer are about 98% for each and for the stroma associated with
these pathologies, both the sensitivity and specificity are more than 90%.

The current

study suggests a further investigation of different grades of PIN pathology: low grade and
high grade, including basal cells, and expand Raman spectral database for better prediction
accuracy. Since some of the PIN structures may not lead to carcinoma, by spectroscopic
investigation one can find the Raman signatures of a PIN structure which can lead to cancer.
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CHAPTER 7
RAMAN SPECTROSCOPIC STUDY OF PEDIATRIC TUMORS
In this chapter, the investigation of the cellular regions in normal adrenal gland and
pediatric

tumors,

specifically

neuroblastoma

spectroscopy is discussed in detail.

and

ganglioneuroma,

using

Raman

Our investigation is the first report of comparison of

frozen and deparaffinized pediatric tissues of the same patients using Raman spectral
signatures.

7.1 Introduction to Neuroblastoma and Ganglioneuroma
Neuroblastoma and ganglioneuroma are peripheral neuroblastic tumors derived from
immature sympathetic nervous system and the adrenal gland.

Neuroblastoma, the third

most common type of children’s cancer, occurs in embryonic neuroblasts of the sympathetic
peripheral nervous system which can spontaneously mature into ganglioneuroma.17 It is a
solid malignant tumor which can be observed in the abdomen, around the spinal cord near
the chest region, or pelvis. MYCN (v-myc myelocytomatosis viral related oncogene) gene
amplification, DNA ploidity, chromosome 1p depletion or loss of heterozygosity, and gain of
17p chromosome are the most vital prognostic markers. 134

Neuroblastoma can be of

favorable or unfavorable histopathology/prognosis based on the Shimada classification.19, 20
When MKI (mitosis-karyorrhexis index, number of mitoses and karyorrhexis per 5,000 cells)
is low or intermediate in neuroblastoma at age less than 1.5 years, these cases belong to
the favorable histology group.

In addition, when the differentiating neuroblastoma is

diagnosed with low MKI between ages 1.5-5 years, the histology group is also favorable. 135
If a child is diagnosed with neuroblastoma, it is frequently unamenable to surgical
removal at diagnosis and requires chemotherapy followed by surgical debulking. Prognosis
is dependent on the patient age, morphological findings such as degree of ganglionic
differentiation, stromal maturation, mitotic/karyorrhectic count and biological molecular
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markers.134 Ganglioneuroma on the other hand is a benign neoplasm that is considered the
end result of spontaneous maturation of neuroblastoma in a subset of patients. This is a
unique phenomenon that is still incompletely understood.

Ganglioneuromas are usually

treated by surgical removal, no chemotherapy is needed and the prognosis is excellent.
Chemotherapy treatment in neuroblastoma also induces ganglionic maturation and stromal
maturation and often neuroblastomas at the time of debulking surgery appear histologically
similar to ganglioneuromas.17

Motivation
Although several Raman spectroscopic investigations have been carried out on frozen
tissues, the abundant availability of archived formalin fixed paraffin preserved (FFPP)
tissues may provide a venue for conducting a thorough investigation for diagnostic purpose.
However, the preservation of tissue specimens by embedding them in paraffin wax is known
to alter their biochemical composition. In a study using human placenta specimens it has
been shown that formalin fixation results in additional peaks as well as shifts in the amide
bands resulting from changes in protein conformation and possible cross-links. 136 Thus, for
a reliable diagnosis of pathological state in deparaffinized or FFPP tissues using Raman
spectroscopy, it is important to identify the biochemical changes which occur in archived
FFPP tissues.

Once the nature of the loss of biochemical information is known and

understood, one can pursue further studies using FFPP tissues using Raman spectroscopy.
Further, the pathological evaluations have inherently an element of subjectivity as the
outcome of the evaluation is based on the experience and intuition of the pathologist. The
information extracted from the pathological evaluations has a high impact in determining
the treatment strategy. Hence, it is crucial to develop an objective optical technique such
as Raman spectroscopy to diagnose the pathological state of tissue with high reliability. The
diagnostic ability of Raman spectroscopy for paraffin embedded archived pediatric
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tumors/neoplasm has not yet been fully explored.

In this study, our aim is investigate

frozen tissue sections of normal adrenal gland, neuroblastoma, and ganglioneuroma
obtained from three different patients, and compared their Raman spectral features with the
corresponding deparaffinized sections of FFPP tissues.

The goal of this study is to

understand the nature of biochemical changes that occur in FFPP tissues and to assess their
feasibility for diagnosis of diseases using Raman spectroscopy.

We have attempted to

determine the Raman spectroscopic signatures of each type of tumor, particularly, from the
cellular regions of well identified pathology rather than collecting data from random sites in
the bulk tissue specimens as was done in the earlier studies.51-53

7.2 Materials and Methods
For this research work, the Renishaw RM1000 Raman microscope-spectrometer (785
nm excitation laser source) was used to collect the Raman spectra.

7.2.1 Normal adrenal gland, Neuroblastoma, and Ganglioneuroma Tissues
For a comparison study of frozen versus deparaffinized specimens using Raman
spectroscopy, the frozen specimens were obtained from three patients from the Children’s
Hospital of Michigan, Detroit, MI. Patient #1 is a 3 year old infant with adrenocortical tumor
present in right adrenal gland. A normal adrenal gland specimen was obtained from this
patient.

The pathology examination verified the absence of any malignant cells in the

tissue. Patient #2 is an 18 month old female infant having neuroblastoma. The specimen
was obtained from the left adrenal gland. The tumor (12 cm in dimension and weight 0.510
kg) was poor in stroma and was poorly differentiated. This neuroblastoma specimen has
been identified as having a favorable histology, and pathological evaluation shows that this
specimen contains nests of tumor cells with centering neuropils. Patient #3 is a 7 year old
child with ganglioneuroma.

The specimen is a spinal mass having differentiating mature
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ganglions in a dominant Schwannian stroma environment.

The tumor was 3 cm  2 cm 

1.5 cm in size, and clusters of ganglions were observed throughout the specimen.
As explained in Chapter 3, these frozen specimens were thawed for about 20
minutes and then the four frozen sections were cut with a microtome using optimal cutting
temperature (OCT) solution. The first cut (5 μm thick section) was stained with
Haematoxylin and Eosin (H&E) for pathological examination and the rest (10 μm thick
parallel sections) which are adjacent to each other were cut for Raman measurements.
Once the tissue sections were obtained, the remaining tissue specimen, keeping the same
orientation, was put in formalin for about 24 hours and subsequently preserved in paraffin
wax. From this tissue block, four additional parallel sections were cut, one for H&E staining
and the rest for Raman spectroscopic investigation.

The paraffin was removed from the

tissue sections using the standard deparaffinizing procedure.

Additionally, we have also

studied archived FFPP tissues from nine other patients.

Cases
No.
1

Patient
No.
P1

2

Pathology

Tissue Source

Normal

Adrenal

Raman
Spectra
78

P2

Normal

Adrenal

11

3

P3

Normal

Adrenal

36

4

P3

Ganglioneuroma

Adrenal

8

5

P4

Ganglioneuroma

Extradural spinal cord mass

20

6

P5

Ganglioneuroma

Abdominal mass

40

7

P6

Ganglioneuroma

Retroperitoneal mass

71

8

P7

Neuroblastoma

Retroperitoneal mass

37

9

P8

Neuroblastoma

Posterior mediastinal mass

68

10

P9

Neuroblastoma

Paraspinal mass

12

Table 7.1 The pathologies and the number of Raman spectra obtained from FFPP tissues of
nine patients 137
The details of the pathologies of these patients are given in Table 7.1.
sections

were

cut

from

these

samples

for

pathological

examination

and

Tissue
Raman
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spectroscopic investigation as described above.

No frozen specimens were available for

these cases.
All the H&E slides were examined by two experienced pathologists who marked the
regions of interest on the slides and the images were taken from each pathological condition
of the tissues. We used the pathologically examined/marked H&E slides of the tissue as a
guide to find the locations of appropriate pathology in the frozen or deparaffinized tissue
sections to collect the Raman spectra. We assume that the pathological state of the tissue
in the 10 μm thick sections is the same as in the adjacent 5 μm thick tissue section used by
the pathologists. We have used three tissues from each state (frozen or deparaffinized) to
collect Raman data.

7.2.2 Data Collection
For a comparison study of frozen versus deparaffinized specimens, a total of 558
Raman spectra were collected: 205 from normal adrenal gland (103 frozen and 102
deparaffinized), 201 were from neuroblastoma (101 frozen and 100 deparaffinized) and 196
were from ganglioneuroma (102 frozen and 94 deparaffinized).
In the second part of the study, FFPP tissue specimens from nine patients were
investigated. The details of the pathologies of these patients and the number of spectra
collected are given in Table 7.1.

A total of 381 Raman spectra were collected from the

tissue specimens. Each spectrum is an average of three accumulations with 20-second
integration time. The power at the sample was 20 mW. The Raman spectra were recorded
in the range of 500 - 1900 cm-1. Each spectrum was recorded on a fresh spot of the tissue.

7.2.3 Data Processing
Each Raman spectrum was visually examined and any cosmic-ray noise was
removed.

The fluorescence background present in the spectrum was removed using a
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customized MatLab program which incorporates an adaptive minmax wavelet method.90
Subsequently, all the Raman spectra were smoothed and their intensities were normalized
with respect to the peak of the highest intensity in the spectrum. To eliminate the influence
of the artifacts which can occur during data processing, we excluded a 100 cm-1 region of
the spectrum at both ends, i.e. the region of the spectrum used was from 600 to 1800 cm-1,
which is commonly known as the “biological window” in Raman spectroscopic studies.
To quantify the spectral differences among the various groups present in the data,
we have analyzed the data using principal component analysis (PCA) and discriminant
function analysis (DFA), both commonly used chemometric analysis techniques in
biomedical research.93,
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PCA is called an “unsupervised” differentiation algorithm and it

lowers the dimensionality of the original data and constructs new fewer variables which
capture most of the variance in the original data.93 It is unsupervised because the identities
of the original sets are not provided in the analysis.

These new orthogonal variables

basically represent the main independent trends in the original data set. In our PCA, 591
Raman intensity channels, or variables, separated by ~2 cm–1, from 600–1800 cm–1 were
used as independent variables, and the PCA reduced them to 18 principal components (PCs)
capturing approximately 96.7% variance in the data sets. The PCs were then used as input
variables for the DFA, which is supervised, and which expresses the data in terms of a
number of discriminant functions (DFs) which is one less the number of groups being
classified.94
In order to assess the utility of FFPP tissues for diagnostic purpose, the Raman data
were collected from the FFPP tissues obtained from nine patients (Table 7.1) and used as
training/reference set to test the data obtained from three patients. For training set, the
classification predictions based on Raman spectroscopy measurements with leave-one-out
method are cross-validated with the "gold standard" results of pathology.
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7.3 Results and Discussion
7.3.1 Comparison of Frozen and the Corresponding Deparaffinized Tissues
Figure 7.1 shows the mean Raman spectra of frozen and deparaffinized tissue
sections, of normal adrenal gland along with the pathology image.

Both tissues produce

good quality spectra with quite sharp and well defined bands. Clearly, there are noticeable
significant differences in the spectra. To highlight the spectral differences, we also show the
difference spectrum in Fig. 7.1.

Figure 7.1 The mean Raman spectra of normal adrenal gland: from top to bottom, frozen
(black), deparaffinized (red), difference (blue), beta-carotene (orange), lipid (dark yellow),
and cholesterol (brown). Pathology image of the normal adrenal gland is taken with 40x
magnification137
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A reduction in the intensity of the bands at 698, 1155, 1439, 1517, 1656, and 1738
cm-1 is evident in the deparaffinized tissue compared to the frozen tissue, while the bands
around 1003 and 1613 cm-1 show enhancement in the intensity. The Raman bands ~1155
and 1517 cm-1 arise from C-C and C=C stretching in carotenoids, which is present in high
concentrations in different human organs including the adrenal gland. 138 The Raman bands
at 1656 and 1738 cm-1 can be assigned to C=O and C-O stretching in lipids.

In the

literature, the band ~1656 cm-1 is often assigned to amide I band of proteins.42 However, it
can also arise from lipids. Thus, the Raman band at 1650 cm-1 is often broad in tissues as it
has C=O stretching contributions from proteins, lipids and other molecular groups whose
frequencies are slightly different. The 698 and 1439 cm-1 (CH2 bend) bands are two of the
strong bands observed in cholesterol and it is generally assigned to "lipids" in the literature,
as lipid also has strong band ~1440 cm-1.
Figure 7.1 also shows the Raman spectra of -carotene, fat, and cholesterol.

A

comparison of the Raman spectra of frozen and deparaffinized tissue sections of normal
adrenal gland clearly indicates that deparaffinizing of the tissue sections with xylene and
ethanol removes lipid, cholesterol, and -carotene. However, the majority of the spectral
features of frozen tissue are preserved in the deparaffinized state.

The other small

differences are in the variation of the band intensities and shifts in the frequencies which
can be understood in terms of the conformational changes and the intermolecular
interactions that occur during the formalin fixing and subsequent deparaffinizing processes.
A reaction of proteins with formaldehyde leading to formation of methylene cross-link has
been described, 139 and such chemical reactions lead to change in the protein configuration
as well as conformation.
Figure 7.2 shows the mean Raman spectra of frozen and deparaffinized tissue
sections of neuroblastoma along with the pathology image.

Compared to the normal
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adrenal gland (frozen tissue section) the neuroblastoma seems to contain no -carotene and
less lipid/cholesterol.

Figure 7.2 The mean Raman spectra of neuroblastoma: frozen (black), deparaffinized (red),
and difference (blue)137
The intensity of the Raman bands ~1580-1600 cm-1 (nucleic acids), 1333 cm-1,
~1250 cm-1 (amide III/nucleic acids), 1100 cm-1 (C-N stretch, nucleic acids), 967, 780, and
743 cm-1 (nucleic acids), and ~664 cm-1 (C-S vibration of collagen type I or nucleic acids) is
higher in neuroblastoma compared to the normal adrenal gland. 140 This indicates that the
neuroblastoma cells are rich in nucleic acids which is consistent with the fact that nuclear
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and cytoplasmic enlargement can occur during the progression of the tumor 141,

142

in

neuroblastic cells.
In this study, the measurements were made from the cellular areas avoiding stromal
regions. The measurements were made specifically from the cellular areas avoiding stromal
regions which are rich in collagen. Typical size of neuroblasts being around 10-20 μm (2 to
3 red blood cell diameters),17 the laser spot is confined to the perimeter of the cell in most
of the cases.

A comparison of the Raman spectra of frozen and the corresponding

deparaffinized FFPP tissue sections of neuroblastoma indicates that the majority of the
spectral features are preserved in the deparaffinized state very similar to that of normal
adrenal gland.
The mean Raman spectrum obtained from deparaffinized neuroblastoma (Fig. 7.2)
tissue sections is very similar to that of the corresponding frozen tissue but with a
somewhat reduced intensity of the overall spectrum. However, from a visual inspection of
the two spectra it is clear that the reduction in the intensity of the bands ~740, ~1250, and
~1580 cm-1 is higher than at other frequencies. These can be attributed to conformational
and configurational changes that occur due to the formalin fixation process as described
above.
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Figure 7.3 The mean Raman spectra of ganglioneuroma: frozen (black), deparaffinized
(red), and difference (blue)137
Figure 7.3 shows the average Raman spectra of frozen and deparaffinized tissue
sections of ganglioneuroma along with the pathology image.

The Raman data were

collected from isolated ganglions (much larger than neuroblasts) and thus the laser spot is
confined to the perimeter of the cell.

Hence, the Raman bands arise from nucleus and

cytoplasm of ganglions. Several Raman spectra from deparaffinized ganglioneuroma tissue
sections showed residual paraffin wax peaks although tissues were processed very similar to
normal adrenal and neuroblastoma. This is perhaps due to the intrinsic differences in the
molecular interaction with paraffin wax in these tissues. It should be noted that the Raman
spectra with residual wax peaks were not included in the analysis.

A comparison of the
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Raman spectra of frozen and the corresponding deparaffinized FFPP tissue sections indicates
that the majority of the spectral features are preserved in the deparaffinized state, very
similar to neuroblastoma and normal adrenal gland.
We also compared the mean Raman spectra of frozen ganglioneuroma (Fig. 7.3) with
that of frozen neuroblastoma (see Fig. 7.2).

There are significant differences observed,

especially in the spectral region of 1530-1630 cm-1 and 1200-1300 cm-1. In both of these
spectral regions the neuroblastoma has more intensity compared to that of ganglioneuroma.
The bands in the 1530-1630 cm-1 region can be assigned to amino acid residues such as
tryptophan and phenylalanine and the bands in the 1200-1300 cm-1 region are assignable to
amide III vibrations arising from the protein backbone. Thus, these intensity variations can
be interpreted as an indication of the variation in the protein content in these tissues.

7.3.2 Chemometric Analysis of Frozen Tissues
To quantify the differences in the Raman spectra of normal adrenal, neuroblastoma,
and ganglioneuroma tissues, we have analyzed the data using advanced chemometric
methods such as PCA93 and DFA.94 Figure 7.4 shows the DF plot of the analysis using the
Raman data for the frozen tissue sections.

Clearly, the analysis separates the data into

three distinct pathological groups representing neuroblastoma, ganglioneuroma, and normal
with no overlap. As there are enough significant spectral differences in the spectra of the
tissues as discussed above, it is not surprising to see this clear-cut separation. A DF plot of
the analysis using the Raman data from the corresponding deparaffinized tissue sections
also shows a similar grouping and separation. This is perhaps due to the fact that the each
type of tissues in this part of the study came from a single patient and thus lacking any
patient to patient variability within a given pathology.
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Figure 7.4 DF plots of the frozen tissue data (left) and the deparaffinized tissue data (right):
normal adrenal gland (green circles), neuroblastoma (red triangles), and ganglioneuroma
(blue squares)137
7.3.3 Chemometric Analysis of Deparaffinized Tissues
In order to address the variability of Raman spectral differences among patients of a
specific pathology we have studied normal adrenal, neuroblastoma, and ganglioneuroma
archived tissues from nine different patients (see Table 7.1).

The tissues were available

only in the form of FFPP blocks without the corresponding frozen tissues.

Figure 7.5 (a)

shows the average Raman spectra of tissues from each distinct pathology as listed in Table
7.1.

It is clear from Fig. 7.5 (a) that the overall shape of the spectra is similar with

observable differences in the intensity and broadening of the bands which are quantified by
the DF analysis.
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(b)

(a)

Figure 7.5 (a) The mean Raman spectra of the archived FFPP tissues: normal adrenal gland
(green), neuroblastoma (red), and ganglioneuroma (blue) and (b) DF plot of the archived
FFPP tissue data137
Figure 7.5 (b) shows DF plot of the PCA-DFA analysis using the FFPP tissue data.
The chemometric analysis does separate the spectra into three distinct groups belonging to
each pathological state of the tissues, although the extent of spread around the group
centroids is considerably larger compared to the analysis shown in Fig. 7.4 (b) for 3
patients.

This could be attributed to the inter-patient variability in nine patients.

The

observed overlap between the ganglioneuroma and neuroblastoma can be understood in
terms of the similarity of their spectra (Fig. 7.5 (a)) and the presence of some ganglions in
neuroblastoma tissues.17
According to leave-one out classification method, the accuracies of the training set
for normal, neuroblastoma, and ganglioneuroma are 100%, 89.7%, and 95%, respectively.
We believe addition of more data to the training set will improve the accuracy of
identification.

However,

the

observed

overlap

between

the

ganglioneuroma

and

neuroblastoma may continue to persist because of the presence of some ganglions in
neuroblastoma tissues and their histologically similar appearance.
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Raman spectral data from the FFPP tissues from the nine patients (Fig. 7.5) were
used as the training set in the chemometric analysis to validate the data from the
deparaffinized tissues (the test set) obtained from the three patients in the first part of the
study.

In this external validation, the test data was fed one patient at a time into the

statistical analysis of the training set without assigning a particular user defined group. The
results are shown in Fig. 7.6.

Figure 7.6 DF plots of the archived FFPP training set with three test patients: normal
adrenal gland (green circles), neuroblastoma (red triangles), ganglioneuroma (blue
squares). From left to right: Patient 1 (black crosses), patient 2 (purple crosses), and
patient 3 (orange crosses)
The analysis of normal adrenal test data grouped correctly ~97% of the time with
the data from the training set.

A similar analysis of neuroblastoma test data correctly

identified and grouped with the training set 100% of the time. However, the identification
was very poor for the ganglioneuroma with ~10.6%, 8.5%, and 80.9% of the time
identifying it as normal, ganglioneuroma, and neuroblastoma, respectively (see Fig. 7.6).
However, it is encouraging to note that only a small percentage of the ganglioneuroma data
are associated with the normal.

The idea behind this external validation is to find the

prediction ability of a new patient data. Although, in this study the test data are from only
three patients, in an ideal scenario, one can divide the total data set into two and test each
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patient of data set 1 against data set 2 and wise versa.

This method provides realistic

values of sensitivity and the specificity of a particular research data.
As seen in Fig. 7.5, the data from neuroblastoma has much larger spread compared
to the normal, and ganglioneuroma.

This is, perhaps, the reason for poor identification.

Addition of more data to the training set may improve the accuracy of identification.
However, the presence of some ganglions in neuroblastoma tissues and their histologically
similar appearance may lead to poor categorization in the case of ganglioneuroma. It has
been observed that chemotherapy treatment in neuroblastoma also induces ganglionic and
stromal

maturation

and

often

neuroblastomas

appear

histologically

similar

to

ganglioneuromas at the time of debulking surgery.17

7.4 Conclusion
We have investigated neuroblastoma and ganglioneuroma using Raman spectroscopy
and compared their spectral characteristics with those of normal adrenal gland. In the first
part of the study, the data were collected from frozen and FFPP tissues, obtained from the
same tissue block, from three patients. The frozen tissue samples produce a high quality
Raman spectra with distinguishable differences compared to the spectra from the
corresponding FFPP tissues.

The frozen sections of normal adrenal gland tissues show

higher levels of carotenoids, lipids, and cholesterol compared to the neuroblastoma and
ganglioneuroma tissues.

A comparison of Raman spectra of frozen and deparaffinized

tissues shows a significant alteration of several biochemicals, including complete removal of
carotenoids, lipids, and cholesterol in adrenal tissues. The chemometric analysis of the data
from both, the frozen and the deparaffinized, tissues show a clear-cut grouping. Our study
shows that the deparaffinized tissues could be utilized for diagnostic research using Raman
spectroscopy. However, its prediction accuracy is less than those of the frozen tissues due
to removal of some of the diagnostic biomarkers by formalin fixation and subsequent
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deparaffinizing processes. At present, it takes ~4 minutes to record a full Raman spectrum
ranging from 500 to 1900 cm-1. However, this time can be reduced by choosing a narrow
wavenumber region relevant to the pathology of interest. As a result, once the database is
established, the total detection time required to identify the pathological state of the tissue
can be reduced to less than 5 minutes.
In the second part of the study, a Raman spectral data set obtained from
deparaffinized tissues from nine different patients was used as a training set against which
the data from the deparaffinized tissues from the first part of the study, the test set, was
validated using chemometric methods.

The validation process successfully identified and

correctly grouped the data with the training set in normal adrenal (>97% of the time) and
in neuroblastoma (100% of the time) tissues whereas the validation was not so strong for
ganglioneuroma. This exploratory study indicates that Raman spectroscopy combined with
chemometric methods can be successfully used to distinguish neuroblastoma and
ganglioneuroma in frozen and deparaffinized tissue sections.

The frozen tissues offer

superior diagnostic outcome compared to the deparaffinized tissues because of their high
quality spectral features and no alteration and loss of biochemicals which occurs in the
process of formalin-fixation, paraffin preservation, and subsequent deparaffinization of
tissues for Raman studies.
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CHAPTER 8
DIFFUSE REFLECTANCE SPECTROSCOPIC/COLORIMETRIC STUDY OF
ACANTHOSIS NIGRICANS
Diffuse reflectance spectroscopy and colorimetry are non-invasive optical techniques
which are beginning to gain acceptance in dermatology.

The physics behind both these

techniques is the same, although analysis of the data produces different parameters based
on different models for each, allowing fundamentally different measurements to be made.
One can determine skin color or monitor skin color changes via both diffuse reflectance
spectroscopy and colorimetry. In this chapter, the results of our attempts to implement an
optical diagnosis of acanthosis nigricans skin condition using both of these optical
techniques are discussed.

8.1 Why Acanthosis Nigricans?
There are many people who suffer from hyperinsulinemia and hypertension and they
are prone to type II diabetes. Acanthosis nigricans (AN), skin thickening and darkening in
various parts of the body, is common among these patients.

If untreated, 90% of the

people who have acanthosis nigricans will eventually get type II diabetes over the next 10
years of their lifetime. There are no optical instruments which can diagnose and quantify
this skin disease. Thus, it is imperative to develop new technologies or even to use existing
optical

instruments

to

develop

the

capability

of

detecting

AN

optically.

These

techniques/instruments should be non-invasive as they will be used for the real time
screening of patients or children, producing point-of-care diagnoses without any timeconsuming laboratory evaluations. This research work is the beginning of such an attempt
to investigate whether diffuse reflectance spectroscopy (DRS) or colorimetry or both
together can be utilized for optical screening of acanthosis nigricans.
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Traditionally, dermatologists have measured skin color through visual observations,
but there is an inherent subjectivity to this type of measurement, as the human eye cannot
quantify small changes in shades of color.

This can be overcome through an optical

diagnostic. A diffuse reflectance spectrophotometer or colorimeter provides a modality for
characterizing the biophysical basis of color on light absorption and the surface properties of
the skin. In DRS, light is delivered onto and into the skin and the reflected light is collected
and analyzed with a broadband spectrometer.

The reflected light spectrum is used to

calculate an apparent absorption spectrum for the skin, which can then be used to calculate
the concentration of known skin chromophores, specifically melanin, oxyhemoglobin, and
deoxyhemoglobin.56 These calculations can be very model-dependent and are also highly
dependent on the spectral distribution of the excitation source, as in colorimetry.

In

colorimetry, a white light excitation source illuminates the skin and the reflected light is
parameterized by the L*a*b* color system as determined by the Commission International
d’Eclairage (CIE) in 1976. 143 Here, L* is the lightness to darkness component and a* and
b* are the color components of red (positive) to green (negative) and yellow (positive) to
blue (negative), respectively. Thus, colorimetry can be used for complex color analysis with
high precision and can accurately determine the spectral reflectance at each wavelength.87
Neither colorimetry nor DRS has been fully explored as a way to study the
hyperpigmentation of acanthosis nigricans. Few studies have directly compared these two
techniques, and none on a single patient pool. Our objective is to evaluate the reliability of
colorimetry in quantifying color change and DRS in characterizing the chromophore changes
associated with AN.

The significance of this lies in the possibility that the degree of a

quantifiable color change may be related to the severity of disease states such as
hyperinsulinemia when assessed in future studies.
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8.2 Materials and Methods
The DRS light source (LS-1 Series Tungsten Halogen Light Source HL-2000,
Mikropack and Ocean Optics, Inc., USA) emits light in the visible to near-infrared range
(360 nm - 2000 nm). This source is connected to one end of a bifurcated fiber optic probe
(measurement/illumination diameter of 2.5 mm), which also collects reflected light into a
spectrophotometer

(BWTEK,

Inc.,

USA).

The spectrophotometer measures diffuse

reflectance spectra in the range of 350-850 nm. These reflectance/absorbance spectra are
used

to

calculate

melanin,

deoxyhemoglobin,

and

oxyhemoglobin

chromophore

concentrations using the known in vivo absorbance characteristics of these complex
biomolecules.78
The colorimeter instrument (Minolta CM-2600d, Osaka, Japan) consists of an 8 mm
diameter measurement/illumination aperture. A pulsed xenon lamp emits an intense white
light covering the entire visible spectrum which illuminates the specimen under the aperture
uniformly. The colorimeter measures L*, a*, and b* values of the reflected light as defined
by the standard CIE system.87 Figure 8.1 shows the L*a*b* color space.

Figure 8.1 L*a*b* color space87
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In order to calculate L*, a*, and b* values, first, tristimulus values need to be
determined.

The tristimulus values, XYZ can be determined through the convolution of

spectral power distribution of the illuminant (stored in the instrument memory), spectral
reflectance of the specimen and the color matching functions ( x( ) , y ( ) , and

z ( ) ) as

shown in Fig. 8.2.87

Figure 8.2 Steps to obtain L*, a*, and b* parameters87

Once XYX values are obtained the L*, a*, and b* can be calculated using the
following equations,
1/ 3

Y 
L*  116   16
 Yn 
 X 1 / 3  Y 1 / 3 
     ---------------------------------------------------------(8.1)
a*  500
 X n 
 Yn  
 Y 1 / 3  Z 1 / 3 
b*  200     
 Yn 
 Z n  
Here, Xn, Yn, and Zn are the tristimulus values of a perfect reflecting diffuser.87
While the colorimetry signal is analyzed purely in terms of the intensity of the
various color components, the DRS data-analysis software modeled the physics of the lightskin interaction to calculate biochemical concentrations from the reflected spectrum.
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Analysis of the DRS data provides a quantification for the contributing skin chromophores,
including melanin, oxyhemoglobin, and deoxyhemoglobin. The subsection 2.3 in Chapter 2
describes how to extract these chromophore concentrations from the spectral information of
the DRS.
Prior to every patient measurement, both instruments were corrected for detector
dark current and were calibrated using manufacturer-provided white and black tile
standards.

8.2.1 Patient Enrollment
Eight female African American patients, ages 12 years and older with AN as
diagnosed by a dermatologist were enrolled.

It is a necessary requirement that all the

patients were in an insulin resistant condition, meaning elevated fasting insulin levels with
normal fasting glucose levels.

During the course of this research, all patients were

consulted by an endocrinologist for treatment of their hyperinsulinemia with diet control,
weight reduction and/or oral metformin.

Patients’ consents were obtained through an

informed consent form and all study-related procedures were explained before enrolling.
Exclusion criteria for patient enrolment was patients with type 1 diabetes, women who were
lactating, pregnant, or planning to become pregnant, and those who were hypersensitive to
oral metformin medication.
A skin prosthesis provided by Henry Ford Hospital was used to assess the
repeatability of the measurements. In addition, we also obtained measurements from nine
healthy volunteers one time to evaluate and compare the DRS and colorimetric
measurements of the healthy control group and the AN patients.
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8.2.2 Data Collection
The pigmented areas were measured from the areas within the AN neck lesion on the
posterior neck and the lateral neck. The inner surface of the forearm and the skin over the
clavicle (normal neck) were treated as normal controls. The probes of both devices were
placed perpendicularly on the skin with light pressure to avoid the skin blanching effect.
Due to differences in the diameter of the probe sizes, the colorimeter obtained 3
measurements at 1 spot, and the DRS obtained 10 measurements at 10 different spots.
The colorimeter probe is approximately 10 times larger in area than the DRS probe.
Photographs of the measurement areas of AN and normal controls were marked so that
subsequent measurements were taken at approximately the same location.

These

photographs were taken every visit to observe and document clinical changes.

All

measurements were taken in an exam room at a dermatology outpatient clinic at Henry
Ford Hospital. Follow-up periods were conducted for 8 consecutive months.

8.2.3 Data Analysis Methods
In the first part of the study, we analyzed the eight month data using standard
analytical methods such as mean, standard deviation, Pearson correlation, etc. and in the
second part of the study we used chemometric methods, principal component analysis
(PCA)93 and discriminant function analysis (DFA)94 to compare the measurements of both
the DRS and colorimetry instruments.

8.2.3.1 Standard Analyses
We calculated the mean and standard deviation values of the 6 model-dependent
parameters (L*, a*, b*, melanin, oxyhemoglobin, and deoxyhemoglobin) of each skin site
for each patient over the eight month period. Also, we determined the differences of the AN
lesion-control sites (normal neck or forearm) for each individual parameter. In determining
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a scatter of measurements for all the patients, we wanted to utilize a single parameter to
interpret the data.

This is because some of the patients exhibited more variance of the

monthly measurements from the average than the others.

Hence, characterizing the

measurement scatter of all the patients around the mean value with a single parameter
assists in determining the sensitivity of the measurement. We call this single parameter a
“global standard deviation”.

Global standard deviations for the three skin measurements

(AN lesion - normal neck, normal neck - forearm, and AN lesion – forearm) were calculated
by measuring the standard deviation of the individual measurements from the average
values for all patients, and then averaging those standard deviations to obtain one global
standard deviation. In addition, we used the Pearson correlation method to evaluate the
correlation between the six parameters (see Table A2).

We also calculated the percent

difference in these parameters between AN lesion and normal skin as described below:

percent difference 

lesion value - normal value
 100% ------------------------------(8.2)
normal value

Changes in these calculated percent differences between visits allow an evaluation of
absolute changes in skin color.

8.2.3.2 Chemometric Approach
It is important to apply a chemometric approach to analyze the spectral data
obtained from these AN patients by colorimetry and DRS to evaluate whether a reliable
classification of skin as “lesion” skin or “healthy” skin can be made more reliably.

A

chemometric model which utilizes more of the data at one time compared to a straightforward calculation of a skin chromophore concentration or the use of individual color
parameters (e.g. melanin concentration or L* value related to skin darkness).

Another

important aspect of the chemometric analysis of the DRS data is its use of only the raw
diffuse reflectance (or absorbance) spectra instead of a reliance on calculated model-
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dependent melanin, oxyhemoglobin, and deoxyhemoglobin chromophore concentrations to
differentiate normal healthy skin from AN lesion. The scattering of light from a medium as
heterogeneous as skin, is a complex phenomenon. Thus, any model of this scattering is at
best an approximation. Moreover, there were also limitations with using this DRS system
for measurement of AN lesions since the original algorithm was designed to evaluate
smooth normal skin.

The use of the entire raw spectrum eliminates this need for an

approximate model and the calculation of any chromophore concentration.
As a result, colorimetry data consisting of the L*, a*, and b* values and the raw
absorption spectra of skin were analyzed separately using two chemometric methods known
as principal component analysis and discriminant function analysis.93, 94
Principal component analysis and discriminant function analysis are statistical
methods which have already been described in detail in Chapter 4. In the PCA of the DRS
data, the entire broadband DRS spectrum (226 channels spanning 450 nm with a 2 nm
channel width) was used as an input data set.

The PCA reduced the 226 variables to 4

variables which captured 99.7% of the variance in the data. These new variables were then
used as the input to the DFA.

The colorimetry data, consisting of only 3 parameters or

variables (L*, a*, and b*) were not analyzed with a PCA.

The raw spectra were not

obtainable from the CM-2600d instrument.
The DFA method classifies the data into the independent groups present in the data
by minimizing the variations within the groups and maximizing the variations between the
groups.94 The DFA constructs N-1 discriminant functions (DFs) for discrimination amongst N
user-defined groups.

Each spectrum can then be classified by N-1 DF scores.

The DF

scores were then used to allow a classification of an unknown sample as “lesion” or
“healthy”. Typically each data set possessed only two DF scores, as we were attempting to
differentiate between only three user-defined groups: control (forearm), control (neck), and
AN lesion.

Although median and lateral AN lesion measurements were obtained, a careful
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analysis showed no difference in these measurements and no utility in separating these
measurements. Therefore, all these lesion measurements were combined in the analysis.
To lessen the between-patient scatter of the measurements due to the inherent
differences in skin coloring and composition of the patients, prior to analysis both
colorimetry data and DRS data were normalized for every patient. This was done by first
calculating the average of the patient’s forearm control measurements. The scatter of the
forearm control measurements about this average allowed us to characterize the anticipated
scatter of the lesion measurements which was expected to be even greater due to the
heterogeneity of the lesion tissue. All subsequent measurements were then divided by that
patient’s average forearm control to insure that data obtained from the neck control or neck
lesion tissue were really differences from that patient’s normal skin coloring or composition.

8.3 Results: Standard Analyses
8.3.1 Reproducibility of Measurements
The reproducibility of the colorimeter and the DRS instrument was measured using a
skin prosthesis obtained from the Orthopedic Department of Henry Ford Hospital twice daily
for 5 days. The percent deviations obtained (pooled standard deviation divided by mean) of
the prosthesis and the forearm of patients are shown in Table 8.1.

Patient#
Prosthesis
1
2
3
4
5
6
7
8

L*
0.20%
0.40%
0.94%
0.80%
0.78%
0.90%
0.61%
0.52%
1.15%

a*
0.12%
1.54%
1.62%
1.66%
1.56%
2.73%
1.00%
1.36%
0.98%

b*
0.18%
0.58%
0.73%
1.10%
0.46%
1.67%
0.68%
0.66%
2.10%

Melanin
10.01%
2.47%
2.42%
2.40%
2.58%
2.90%
1.69%
2.78%
2.15%

Oxyhemoglobin
19.31%
23.07%
20.40%
32.47%
26.85%
33.49%
37.87%
36.50%
36.22%

Deoxyhemoglobin
20.87%
11.44%
8.81%
8.44%
5.39%
10.46%
9.97%
11.33%
9.74%

Table 8.1 Percent deviations for prosthesis and patients
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The colorimeter parameters, L*, a*, and b* values showed a reproducible results,
deviating by less than 1% in the prosthesis.

Most of the patients also indicated low

deviations close to 1%. In contrast, the DRS instrument exhibited significant variance in
the values calculated for the chromophores.

The melanin percent deviation of the

prosthesis is about 10%, whereas oxyhemoglobin and deoxyhemoglobin are approximately
20%.

Surprisingly, the DRS measurements on patient skin showed a very low deviation

(<3%) for melanin. Deoxyhemoglobin deviation was in the range of approximately 5% to
10%, while oxyhemoglobin deviation ranged from approximately 20% to as high as 38%.
Although it may seem intuitive that an unchanging substrate such as the prosthesis
would give reproducible values for melanin concentration, it appears that the absence of the
actual chromophores leads to variable results. Also the skin prosthesis is not a
homogeneous calibrator. Melanin values on patient skin showed a very good reproducibility,
of about 3%. The hemoglobin values showed significant variation in the prosthesis as well
as all patients.

This may be due to the physiologic effect of blood vessels affecting the

hemoglobin concentration. Therefore, the hemoglobin concentration was not a good
parameter to monitor the changes in skin color, and as such has little value as diagnostic
parameter for use in measuring AN skin.

8.3.2 Changes in Pigmentation
In order to determine the changes in the pigmented areas month-to-month basis,
the posterior neck lesion measurements were compared to the control data.

Figure 8.3

shows both colorimetry and DRS parameter difference of AN lesion and forearm skin (black
squares) and also the difference between normal neck and forearm (red stars) for a single
patient (Patient 1).
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Figure 8.3 Patient 1; comparison between normal neck-normal forearm and AN lesion skinnormal forearm 144
It is noted that almost all of the measurements fall within one standard deviation of
the average and show no discernible trend with time, a result consistent with no change in
value over the course of 8 months. The difference of normal neck and forearm values, for
all the parameters is relatively close to zero. Thus, normal neck and forearm values are
very similar. As a result, the comparison of the difference between normal neck skin and
AN lesion skin is plotted in Fig. 8.4.

This skin difference is much more realistic for

diagnostic purposes as the characteristics of forearm skin may be different from a normal
neck area.
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Figure 8.4 Patient 1; comparison between AN lesion skin-normal neck

8.3.3 Scatter of the Measurements
In Figs. 8.3 and 8.4, the averaged values show as dashed horizontal lines.

This

serves as scatter of the measurements in the instruments. Global standard deviations for
calculated melanin, oxyhemoglobin, and deoxyhemoglobin of AN lesion-normal neck
measurements were 0.28, 0.09, and 0.19, respectively. The global standard deviations for
L*, a*, and b* were 2.26, 0.81, and 1.17, respectively.

In Fig. 8.4, the shaded regions

show the global standard deviations about their mean and represent the spread of this
patient’s AN lesion–neck normal measurements over the 8-month period. Similarly, shaded
regions in Fig. 8.3 show the global standard deviations of normal neck-forearm and AN
lesion-forearm for all the six parameters.
As can be seen in Fig. 8.4, the ∆L* values for the lesion tissue relative to normal
neck tissue were -12.1. This is approximately 5.4σ from the normal neck average. All the
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eight patients showed differences between normal neck and lesion greater than 3σ. In fact,
b* values also showed more than a 3σ difference between normal neck and AN lesion for all
the 8 patients.

However, a* varied from 0.14σ to 8σ and did not show a consistent

difference.
Among DRS parameters, only melanin, showed a potential to be an effective
discriminator.

The average AN lesion-normal neck skin value, 0.78, a difference of

approximately 2.8σ, which is above a 95% confidence level.

With the exception of one

patient (Patient 8), all patients showed more than a 2σ statistical difference for melanin
concentrations measured in AN lesion skin compared to normal neck skin. Patient 8 also
showed a higher concentration of melanin for lesion skin, but it was not statistically
significant enough to reliably differentiate AN.

Oxyhemoglobin rarely showed any

statistically significant difference between AN lesion tissue and healthy neck tissue (see
Figs. 8.3 and 8.4).

Deoxyhemoglobin showed a difference in some patients (including

patient 1), but not all patients.

8.3.4 Evaluation of Lesion Visit-wise
The absolute difference of AN lesion and normal skin were determined through L*,
a*, b*, melanin, oxyhemoglobin, and deoxyhemoglobin values obtained from these two
instruments (e.g. L*  L*(lesion) – L*(normal)). The percent difference were calculated in
these parameters between visits, but none of the patients showed any statistically
significant change between visits in the percent differences of the six parameters during the
eight month testing period. This was also confirmed by periodic insulin level measurements
which remained relatively constant for all the patients.
diagnosis of AN remained unchanged.

In addition, dermatological
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Figure 8.5 Dermatological images of the 8 visits of a patient

For a single patient, photographs taken for eight visits were shown in Fig. 8.5. Thus,
spectroscopic measurements, insulin measurements, and dermatological observations all
confirmed no change in AN condition during this eight month period.

8.3.5 Healthy Volunteers’ Measurements
Similar to AN patients’ measurements, DRS and colorimetry measurements were
obtained from the same skin areas including posterior neck from nine healthy volunteers.
These measurements were made only once for all the healthy volunteers, but used the
same protocols as on the patients, specifically with reference to the number of
measurements and sampling locations.
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Figure 8.6 Comparison of colorimetry and DRS measurements made on control subjects and
diagnosed AN patients. (left) Difference of the colorimetry data (L*, a*, b*) obtained from
the posterior neck and normal neck measurements for both control subjects and patients.
(right) Difference of the DRS-calculated concentrations (melanin, oxyhemoglobin, and
deoxyhemoglobin) obtained from the posterior neck and normal neck measurements for
both control subjects and patients. The data points with error bars represent the control
subjects and the blue shaded areas represent the patients’ standard deviation around the
mean
Figure 8.6 compares the difference between the measurements made at the
potential lesion site and the neck normal site for patients and controls. Figure 8.6 shows
each of the three parameters obtained from DRS and colorimetry showing the difference of
posterior neck and normal neck for a total of six graphs. Each graph shows the average
value of the patient data (obtained by averaging the value from all 8 patients) with 1σ (blue
band around the average dashed line). The uncertainties of individual volunteers for each
parameter are also shown in each graph. L*, a*, and b* show a difference of -3.92, -1.02,
and

-3.25,

respectively

while

DRS

parameters,

melanin,

oxyhemoglobin,

and

deoxyhemoglobin show 0.22, -0.02, and -0.12 respective differences. The difference
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between the control average and patient average for each of the six parameters is also
calculated, and expressed in units of standard deviation. These results are shown in Table
8.2, where there is about a 4σ difference in L* and b* values between the average of the
healthy volunteers and the patients. Note that a zero difference is interpreted as “healthy”.
As the control subjects’ difference (healthy posterior neck-NN) is rather close to the zero,
this gives us confidence that the patients are showing statistically significant differences in
AN lesion compared to the control data.

L*

a*

b*

Melanin

Oxy

Deoxy

3.8

1.8

3.9

1.8

0.5

1.4

Table 8.2 Difference in patient average and control subject average for each of the six
measured parameters expressed in units of sigma (the standard deviation of the patient
measurements)
Note that, if two values are within 1σ of each other there is a 32% possibility that
this happened by chance. If two values differ by 2σ there is only about a 5% possibility that
this is by chance, and if two values differ by 3σ there is only a 0.3% possibility that it occurs
by chance. Therefore, two values that differ by 3σ or more are almost certainly statistically
different. L* and b* seem to satisfy this criterion. It can also be seen that none of the
control measurements fall within the uncertainly of the patient average, as expected. For
the other four parameters, the differences are all less than 2σ, and thus more uncertain.
This can be seen in the graphs, where control subject measurements frequently fall into the
blue uncertainty band of the patient data.

8.4 Discussion: Standard Analyses
In this research work, the reproducibility of the colorimeter and DRS was examined
on skin prosthesis and on normal skin of patients with AN.

Colorimetry showed a high

reproducibility in both prosthesis and in vivo skin measurements, with variation below or

126

near 1% in most cases.

The slightly higher variation for in vivo measurements can be

explained by small month-to-month variations present in normal skin.

We can conclude

from these measurements that colorimetry values for L* and b* may be reliable modalities
to objectively quantify skin color in pigmented areas of skin, while a* is a weak indicator of
skin color, and thus not reliable.
When determining the difference between AN lesion skin and normal skin, it was
important to use normal neck skin as the control, and not forearm skin. As can be seen in
Fig. 8.3, neck skin varied on a month-to-month basis when compared to forearm skin in AN
lesion as well as normal neck.

This variation may be caused by sun exposure or other

factors. This month-to-month change is less apparent in Fig. 8.4, which compares AN lesion
skin to normal neck skin.
The scatter of these instruments was determined to distinguish the intensity of the
pigmented skin caused by AN from the intensity of the pigment from normal skin. L* and
b* color parameters obtained from the AN lesion were shifted by more than a 3σ difference
from correspondingly healthy neck tissue for all the patients, which corresponds to less than
0.27% chance that the measurement differed by chance alone.

These parameters are

therefore sensitive enough to differentiate AN from normal pigmented skin color. However,
no parameters obtained from DRS showed sufficient sensitivity to diagnose AN for all the
patients. Melanin concentration in the AN lesion showed a significant statistical difference of
more than 2σ from the correspondingly healthy neck in all the patients except Patient 8.
None of the patients showed a greater than 3σ difference in oxyhemoglobin or
deoxyhemoglobin concentration.
By performing a Pearson correlation analysis on the data measured by both
instruments, we found a strong negative correlation between L* and melanin values (see
Table A2). This means when L* increases, melanin should decrease. We also found that L*
and b* decrease while melanin increases in AN compared to normal skin. In addition, the
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results of the percent difference from normal for the first four months of the trial are shown
in Table A3.

We found that L*, b*, and melanin values measured in AN lesions were

different from normal skin with statistical significance, as shown by their very low p value
(P-value <0.001).

This p-value analysis implied that L*, b*, and melanin could be good

parameters to objectively quantify skin color in AN lesions, as L* and b* values tended to
be lower while melanin values were higher in lesion tissues. Data in subsequent months
was similar. Taken together, this suggests that the hyperpigmentation of AN may have a
higher melanin content than the normal pigmented skin. This study supports the conclusion
that the brown color of AN is caused by hyperkeratosis of the epidermis as well as increased
melanin content. 145, 146,
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L* and b* seem to be consistent measures of skin color in AN lesions, as the
measurements

obtained

from

patients

are

very

different,

statistically,

than

the

measurements obtained from the healthy volunteers. Although a* and melanin values are
indeed indicative of a change in AN patients (relative to healthy controls), they do not
appear to be reliable. Further experiments need to be carried out to draw any conclusions.
The oxyhemoglobin and deoxyhemoglobin values do not show a significant difference
between patient and healthy volunteers’ data, therefore we would conclude, that these
values are unreliable for use as an objective color measurement of AN.
A significant limitation of the DRS instrument is that the size of the measurement
probe is being small.

Therefore, DRS is ideal for skin lesions which are homogeneous or

smaller in size where the illuminated spot size needs to be smaller than the integrating
sphere aperture of the colorimeter.76 Another limitation to this study was the fact that AN,
as well as other skin conditions, possesses a velvety, rough texture, which causes
significant light scattering at the skin surface. A larger DRS probe would be able to capture
the light that is reflected from these relatively large surface features.
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8.5 Results and Discussion: Chemometric Approach
The mean DRS absorbance spectra of the three measurement sites for one patient
are shown in Fig. 8.7. Absorbance is a unitless quantity obtained from the diffuse
reflectance spectrum. Each of the three spectra shown in Fig. 8.7 is the average of the all
the measurements made at that particular site. Regions of large absorbance indicate strong
absorption or scattering of the light at that wavelength, sometimes indicative of the
presence of a specific chromophore.

Figure 8.7 Mean absorbance spectra of forearm control, neck control, and lesion. Lesion
tissue obviously demonstrates significantly greater absorption/scattering91
In Fig. 8.7, a clear increase in the absorbance of the lesion can be seen compared to
the normal controls (forearm and neck).

This is indicative of an increase in the

concentration of the chromophores melanin, oxyhemoglobin, and deoxyhemoglobin, as was
shown in our previous analysis of these patients.

Aside from this overall increase in

absorbance, statistically meaningful and reproducible spectral differences are hard to
quantify in the three spectra shown in Fig. 8.7.
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Chemometric techniques provided a more reliable way to obtain quantitative
classification of the differences in the spectra.

Figure 8.8 shows the first two discriminant

function scores of the DFA performed on (a) the normalized DRS data (subject to PCA first,
as explained above) and (b) the colorimetry data obtained from all eight patients spanning
all patient visits.

Figure 8.8 Discriminant function plots for (a) DRS and (b) colorimetry data obtained from all
patients over the course of this study91
In the DFA results, DF1 expresses the maximum variance of the data and DF2
contains the rest of the variance in the data. It is evident that while there is some overlap
of individual measurements, the center of mass of the lesion data distribution (shown as the
labeled dark square in Fig. 8.8) is well separated from the centers of mass of the
distribution for the two controls. The reversal of the DF1 scores for the two modalities (i.e.
positive DF1 lesion scores for DRS and negative DF1 scores for colorimetry) has no physical
significance and is purely a computational artifact. The fact that all the patients’ data can
be clustered significantly implies that the variations of the lesion tissue from the control
sites are reproducible and similar in all patients.
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8.5.1 Classification
A leave-one-out (LOO) classification was also performed for both data sets.

In a

LOO method, each data point is treated as an unknown case and is classified against a data
set consisting of all the other data points.

The accuracy of that classification is then

compared to the known identity of the data point to create a truth table. The truth tables
for both spectral methods are shown in Table 8.3. The interpretation of these truth tables is
as follows:

true positives (TP) indicate a lesion measurement was correctly classified as

lesion. True negatives (TN) indicate a normal control measurement was correctly classified
as normal.

False positives (FP) indicate a normal control measurement was incorrectly

classified as lesion.

False negatives (FN) indicate a lesion measurement was incorrectly

classified as normal.

DRS (%)
True
Positive
91.4
Negative
95.1

False
4.9
8.6

Colorimetry (%)
True
False
Positive
98.4
3.9
Negative
96.1
1.6

Table 8.3 Truth tables for leave-one-out classification results of (a) DRS and (b)
colorimetry91

Colorimetry data showed the highest true positive and true negative results, 98.4%
and 96.1% respectively, which confirmed our earlier result that colorimetry seems to be
more efficacious for diagnosing AN than DRS as we currently perform it.

Impressively,

when analyzed with the PCA/DFA the DRS data showed more than 91% sensitivity
(TP/TP+FN) and specificity (TN/TN+FP), which was not the case for the standard statistical
analyses as reported in subsection 8.3.
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8.5.2 External Validation
In the previous leave-one-out analysis, an unclassified measurement was classified
with a set of discriminant functions constructed using all the other data points, including
other data points from that same patient. However, if either of these techniques is to be
used for patient screening, it is not realistic to expect the discriminant functions to have
been constructed with any data from that patient.

Therefore, we performed a DFA

excluding one patient at a time from the analysis. Unclassified lesion and neck control data
from that patient were then input to the DFA (which contained none of that patient’s other
data) and were classified according to the library of results from other patients. The truth
tables for this analysis are shown in Table 8.4.

DRS (%)
True
Positive
87.7
Negative
94.8

False
5.2
12.3

Colorimetry (%)
True
False
Positive
97.2
5.4
Negative
94.6
2.8

Table 8.4 Truth tables for patient exclusion classification results of (a) DRS and (b)
colorimetry91

As expected the rates of true positives and true negatives declined, although only by
a small amount (by 3.7% and 0.3% for DRS and 1.2% and 1.5% for colorimetry) and rates
of false positives and false negatives increased (by 0.4% and 3.7% for DRS and 1.5% and
1.2% for colorimetry). These results show a more realistic truth table for the techniques if
they were to be used to screen previously unexamined patients for AN.
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Figure 8.9 DF plots showing (a) DRS and (b) colorimetry data with patient 8’s lesion data
input as unclassified data into the analysis. This patient’s lesion data, which clustered well
with itself, was significantly different from the mean of the other patients’ lesion data.
Nonetheless, it was easily and reliably classified as “lesion” in both analyses91
One of the strong benefits of using a chemometric approach is shown in Fig. 8.9
which shows the DF plot of the patient exclusion analysis for patient 8. Patient 8 was the
only case in our previous analysis that did not show a 3σ standard deviation between the
calculated melanin concentration in the forearm control and the AN lesion indicating that
this patient’s lesion tissue was very hard to diagnose spectrally. Nonetheless, in Fig. 8.9,
when patient 8’s lesion data was entered as unclassified data into the DFA (shown as x
symbols in Fig. 8.9), almost all of the measurements were easily classified as “lesion”
compared to the forearm control or the neck control.
Although forearm and neck controls were both used as normal controls in this AN
study, the more realistic site for a normal control is the neck normal (which should have
similar properties compared to the lesion measurement site due to tanning, aging, etc.).
This can be observed by the neck control data being closer to the lesion data than the
forearm control data in Figs. 8.8 and 8.9.
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8.5.3 ROC Curves
It was vital to know the sensitivity and specificity of the lesion site measurements as
compared to the neck control. To investigate this, receiver operating characteristic (ROC)
curves were constructed using the DF1 values of the DRS and colorimetry data to act as a
“cut point” to discriminate lesion and neck control data (discarding the forearm control
data).

Figure 8.10 ROC curves of a test to differentiate neck control measurements from lesion
measurements as shown in Fig. 8.8 on the basis of the DF1 score alone for (a) DRS and (b)
colorimetry data. The area under the curves for (a) was 0.985 and for (b) was 0.99591
In a ROC curve114, the sensitivity of the technique (as defined above) is plotted
against 1-specificity (as defined above). ROC curves are shown in Fig. 8.10 for DRS (a) and
colorimetry (b). The ROC area under the curve (AUC) establishes the usefulness of the test,
with an AUC of 1.0 denoting a perfect test, and an AUC of 0.5 denoting a worthless test.
The ROC curves of Fig. 8.10 possess an AUC of more than 0.98, indicating a highly reliable
test for this AN investigation.
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8.6 Conclusions
In the standard analytical methods, the average values that differed by more than
3σ were considered to be valuable predictors of the presence of lesion tissue. Of the three
CIE L*, a*, and b* parameters, the luminosity parameter “L*” was found to most reliably
distinguish lesion from normally pigmented skin. b* also showed more than 3σ statistical
difference between AN lesion and the skin control sites and a* was considered as a weak
indicator.

The calculated melanin concentration of the DRS instrument was able to

characterize a lesion as compared to normally pigmented skin on the neck, though melanin
is a weak indicator of skin change and not a reliable measure to be used independently.
However, oxyhemoglobin and deoxyhemoglobin concentrations were not found to be reliable
indicators of AN.
Spectroscopic and colorimetric measurements combined with chemometric analysis
methods provided sensitive and specific diagnoses of acanthosis nigricans lesions compared
to nearby control skin. Analysis of raw DRS absorbance spectra showed clear clustering of
normal controls and lesion groups (Fig. 8.8 (a)) for all patients denoting a commonality that
may allow diagnosis of previously unmeasured lesions. Colorimetry data also showed the
ability to reliably identify AN lesions (Fig. 8.8 (b)). Excluding patients one at a time from a
DFA model and then testing that patient’s spectral data with the model constructed only
from other patient measurements provided a realistic simulation of an acanthosis nigricans
screening test.

DRS data provided more than 87% sensitivity and 94% specificity and

colorimetry data showed more than 95% sensitivity and specificity (Table 8.4) in this type
of test. ROC curves also confirmed that the use of a discriminant function analysis on DRS
and colorimetry data can provide a sensitive and specific AN test even when only the DF1
score is used to assess skin condition.
Unfortunately, none of the patients showed any improvement in acanthosis nigricans
from treatment during the duration of this study which was also confirmed by visual and
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photographic observations. Thus, the changes in skin DRS and colorimetry data that occur
during the healing process of AN could not be established.

However, the existing data

showed both DRS and colorimetry can be used as a successful diagnostic tool for acanthosis
nigricans when combined with chemometric methods such as PCA and DFA.
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CHAPTER 9
CONCLUSIONS AND FUTURE WORK
This

chapter

summarizes

the

conclusions

drawn

from

Raman

spectroscopic

investigations of head and neck squamous cell carcinoma, prostate cancer, and pediatric
tumors, and also summarizes the results of identifying acanthosis nigricans skin disease
using diffuse reflectance spectroscopy and colorimetry followed by future work.

9.1 Conclusions
Head and Neck Squamous Cell Carcinoma: Tongue Tissues
We have studied the Raman spectral characteristics of normal, carcinoma in situ, and
invasive squamous cell carcinoma (SCC) tissues of tongue. There are substantial spectral
differences in the observed spectra of these tissues and we were able to identify the
spectral features that can discriminate these three tissue types. We were able to assign the
observed spectral changes in the intensities of certain Raman bands to specific molecules or
category

of

molecules,

and

thus,

draw inferences

on

the

nature

of

biochemical

compositional changes in these tissues (see Chapter 5). We found tryptophan to increase
while keratin to decrease when the tissue changes from normal to invasive SCC.

The

analysis of Raman spectral data using chemometric methods, principal component analysis
(PCA) and discriminant function analysis (DFA), clearly separated the data into three distinct
groups consistent with results of pathology. We were able to distinguish with 91% success
rate the normal and carcinoma in situ tissues, and with 89% accuracy the invasive SCC
tissues of tongue. This exploratory study suggests that Raman spectroscopy can be used to
distinguish normal, carcinoma in situ and invasive SCC.111
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Prostatic Intraepithelial Neoplasia
In this study, we investigated the benign, prostatic intraepithelial neoplasia, and
difference cancer grades in FFPP tissues using Raman spectroscopy. The tissue specimens
used in the study were obtained as radical prostatectomy and each of the diseased tissues
contained regions with three pathologies mentioned above.88

We found that, even with

other pathologies present in the tissue, Raman spectroscopy can differentiate each
pathological state through careful investigation of epithelia.
contain signatures from both luminal and basal cells.

Thus, the Raman spectra

Further, Raman spectroscopy was

able to classify the tissues with Gleason scores of 6, 7, and 8 with more than 85% accuracy.
As a part of this study, we also investigated the luminal cells of benign epithelia, prostate
intraepithelial neoplasia, and cancer using additional 34 patients’ specimens.133 The reason
being, that basal cells are not present in cancerous micro acinar structures. These tissues
contain only one pathology, either BE, PIN or cancer (Gleason grade 3). Our aim was to
diagnose PIN pathology and compare and contrast its Raman spectral features with that of
BE or cancer.
Chapter 6.

The study did show difference in the spectral features, as discussed in

We also examined the Raman fingerprints of stromal cells around each

pathological state: BE, PIN, and cancer. The spectral data was analyzed with PCA and DFA,
and were able to classify the data into distinct pathological groups with very high accuracy.
The sensitivity and specificity of luminal cells of PIN and cancer were about 98% for each
and for the stroma associated with these pathologies the sensitivity and specificity were
more than 90%.133

Pediatric Tumors: Neuroblastoma and Ganglioneuroma
In

this

work,

we

investigated

the

cellular

regions

in

neuroblastoma

and

ganglioneuroma using Raman spectroscopy and compared their spectral characteristics with
those of the corresponding normal adrenal gland.

Thin sections from both frozen and
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formalin-fixed paraffin processed (FFPP) tissues, obtained from the same tissue block, were
studied in conjunction with the pathological examination of the tissues. Investigation of the
spectral data showed that the normal adrenal gland tissues have higher levels of
carotenoids, lipids, and cholesterol compared to the neuroblastoma and ganglioneuroma
frozen tissues137.

However, in comparison to the frozen tissues the FFPP tissues show a

significant alteration in several biochemicals, including complete removal of carotenoids,
lipids, and cholesterol in adrenal gland tissues as shown in Chapter 7.
The quantitative analysis, of the Raman data obtained from the frozen tissues, using
PCA and DFA showed a clear-cut classification among pathological groups with high
sensitivity and specificity.137

This study showed that Raman spectroscopy combined with

chemometric methods can be successfully used to distinguish neuroblastoma and
ganglioneuroma at cellular level in frozen tissue sections. Further, the nature of chemical
changes that occur in processing and preservation of these tissues were evident in Raman
spectra, and thus suggesting that one can also use the FFPP tissues for optical diagnosis
using Raman spectroscopy.

Acanthosis Nigricans: Diffuse Reflectance Spectroscopy/Colorimetry
In

this

study,

we

investigated

acanthosis

nigricans

(AN)

skin

diseases,

hyperpigmented velvety plaques in skin using diffuse reflectance spectroscopy (DRS) and
the colorimetry in vivo.

The non-invasive optical technique DRS provides information on

skin melanin, oxyhemoglobin, and deoxyhemoglobin content through the measured
absorption spectrum whereas colorimetry measures the skin color based on the standard
Tristimulus values (so called L*, a*, and b* parameters). Measurements were conducted
on eight AN patients, spanning eight months of treatment by diet control and/or oral
metformin.

The study indicated an increase in melanin concentration AN lesion areas

compared to the normal control sites. L* and b* show a significant differences between AN
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lesion and normal controls, and a* and melanin are weak indicators.144

In fact,

oxyhemoglobin and deoxyhemoglobin didn’t show any significant differences what so ever,
so they are not reliable for the screening of AN.
PCA and DFA of the spectral data provided more robust results compared to the
standard analytical methods in attempting to classify an undiagnosed skin sample as
“lesion” or “healthy.”

PCA-DFA successfully differentiated between AN lesion and normal

skin controls with 87.7% sensitivity and 94.8% specificity in DRS measurements, and
97.2%

sensitivity

and

96.4%

specificity

in

colorimetry

measurements.137

These

chemometric methods provided a better diagnostic ability than skin chromophore
concentration calculations based on DRS data.
Both spectroscopic measurements, dermatological evaluations, and insulin level
measurements showed no change in AN patients between the chronological visits to their
doctors. Thus, we could not draw any conclusions regarding suppression of AN as none of
the patients healed during the course of this research work.

9.2 Future Work
The investigation of the head and neck squamous cell carcinoma, prostate cancer,
and pediatric tumors using deparaffinized tissue sections from archived paraffin embedded
blocks has lots of advantages. The easy access to these archived tissue blocks reduces the
waiting time to obtain a fresh tissue sample from a patient. Since, there are a large number
of tissue specimens available in the archives, a large Raman spectroscopic data can be
collected for different types of cancers. In order to validate any hypothesis, it is important
to have the analysis done with a large data set.

However, a prior knowledge of loss of

Raman information upon preserving the tissues using formalin fixating and embedding in
paraffin is very important. Our study has documented this in the case of pediatric tumors,
where, we studied the spectral difference between frozen and their corresponding FFPP
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tissues. The nature of changes that occur in preserving the tissues for archival purposes
could be different for different types of tissues and the type of cancer. Thus, one needs to
investigate the nature of changes that entail tissue archival in different types of cancers
using

frozen

and

their

corresponding

preserved

tissues

spectroscopy for diagnosis using the archived FFPP tissues.

before

using

the

Raman

The investigation of frozen

tissues seems more realistic and useful as the frozen tissues produce Raman spectra similar
to the fresh tissues.

By increasing spectral database for the frozen tissues of different

cancer types, one can use this technique as an additional tool to obtain complementary
information about the state of a disease or cancer to augment the pathological evaluations.
Pathological evaluations can be subjective depending on the experience of the pathologists.
Raman spectroscopic detection may provide new means for disease/cancer detection, in
vitro or in vivo.
Regarding prostate cancer investigation, it is an established observation that a
prostate gland exhibiting PIN cell architecture may or may not progress to carcinoma. So,
the fundamental and most important issue here is to determine which cell architecture will
lead to cancer.

Thus, future studies could focus on finding the unique Raman spectral

features of the PIN cell architecture that leads to carcinoma.
Regarding, optical diagnosis of acanthosis nigricans, there are certain draw backs.
The main disadvantage is the difficulty in enrolling new patients into this research project.
Even if new patients enroll, some of them abandon the research study in the middle of the
study period.

Another disadvantage is that although the patients are advised not to

consume any food during fasting insulin level measurements, this cannot be strictly
controlled.

If this happens, the measured values have to be discarded from the study.

Although, the patients are supposed to control their diet and are advised on exercising to
control and get better from this AN skin disorder, as researchers, we do not have the
control over the patients’ activities but one can minimize these issues with close doctor-
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patient relationship and motivating the enrolled patients to remain in the study. One could
also conduct this study on other ethnic groups, although, AN is common among AfricanAmericans using other ethnic groups may provide dependence on skin type.
This study also suggests that we can use a different predictor of the patients’ insulin
level. That would be the hemoglobin A1c test, which does not require fasting. This test
provides a reliable measure to know whether the patient’s blood glucose level for the
previous 3 months is persistently elevated or not. Thus, more meaningful results can be
obtained by conducting this research work for about 5 years.
In a near-perfect scenario, one can determine the skin changes during the healing
process using diffuse reflectance spectroscopy/colorimetry and correlate the measurements
with serum insulin level and insulin sensitivity in AN.

Then, this particular skin disorder

becomes a diagnostic parameter for insulin-resistant obese AN patients to evaluate the
insulin sensitivity.

The ultimate objective is to replace the time consuming and resource

extensive procedures of blood collection and laboratory evaluations of obese patients having
AN by non-invasive DR measurements.
Furthermore, we can strengthen the statistical/chemometric analysis by increasing
the size of the data set.

For a large enough data set, PCA-DFA analysis can be used to

propose a reliable model. Then using this model, one can validate the new data set with the
proposed model.

The alternate advanced chemometric methods such as partial-least

square regression method or support vector machines method could be used to analyze the
Raman or diffuse reflectance spectral data to assess the discrimination ability of these
techniques compared to the PCA and DFA.
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APPENDIX A
SUPPLEMENTARY TABLES

Raman Shift
(cm-1)
Pearson

753

850

933

1235
/40

1306

1335

1365

1446

1562

1584

1614

1650

1

-.064

-.010

-.356

-.484

-.219

.712

-.461

.809

.616

.744

-.464

.200

.836

.000

.000

.000

.000

.000

.000

.000

.000

.000

1

.717

.191

.357

.224

-.517

.283

-.501

-.666

-.495

.533

.000

.000

.000

.000

.000

.000

.000

.000

.000

.000

1

.062

.236

.183

-.310

.181

-.280

-.444

-.206

.293

.217

.000

.000

.000

.000

.000

.000

.000

.000

1

.915

.874

-.086

.609

-.475

-.346

-.268

.573

.000

.000

.085

.000

.000

.000

.000

.000

1

.911

-.262

.759

-.641

-.537

-.438

.649

.000

.000

.000

.000

.000

.000

.000

1

.103

.681

-.335

-.251

-.122

.510

.039

.000

.000

.000

.015

.000

1

-.197

.851

.843

.879

-.474

.000

.000

.000

.000

.000

1

-.558

-.410

-.501

.620

.000

.000

.000

.000

1

.892

.929

-.646

.000

.000

.000

1

.838

-.552

.000

.000

1

-.670

753
Sig.
Pearson

-.064

Sig.

.200

Pearson

-.010

.717

Sig.

.836

.000

Pearson

-.356

.191

.062

Sig.

.000

.000

.217

Pearson

-.484

.357

.236

.915

Sig.

.000

.000

.000

.000

Pearson

-.219

.224

.183

.874

.911

Sig.

.000

.000

.000

.000

.000

Pearson

.712

-.517

-.310

-.086

-.262

.103

Sig.

.000

.000

.000

.085

.000

.039

Pearson

-.461

.283

.181

.609

.759

.681

-.197

Sig.

.000

.000

.000

.000

.000

.000

.000

Pearson

.809

-.501

-.280

-.475

-.641

-.335

.851

-.558

Sig.

.000

.000

.000

.000

.000

.000

.000

.000

Pearson

.616

-.666

-.444

-.346

-.537

-.251

.843

-.410

.892

Sig.

.000

.000

.000

.000

.000

.000

.000

.000

.000

Pearson

.744

-.495

-.206

-.268

-.438

-.122

.879

-.501

.929

.838

Sig.

.000

.000

.000

.000

.000

.015

.000

.000

.000

.000

Pearson

-.464

.533

.293

.573

.649

.510

-.474

.620

-.646

-.552

-.670

Sig.

.000

.000

.000

.000

.000

.000

.000

.000

.000

.000

.000

850

933

1235/
40

1306

1335

1365

1446

1562

1584

1614
.000
1

1650

Table A1 Pearson correlation with 2-tailed significance for selected 12 Raman bands in head
and neck squamous cell carcinoma (see Chapter 5)
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Parameters

∆L* / ∆melanin
∆a* / ∆ HbO2
∆b* / ∆Hb

1st-2nd
month
-0.50
(0.31)
-0.32
(0.54)
0.09
(0.87)

Pearson Correlation Coefficient (r)
(P-value)
1st-3rd
1st-4th
1st–5th
month
month
month
-0.48
-0.67
-0.88
(0.33)
(0.22)
(0.12)
-0.29
0.29
0.76
(0.58)
(0.63)
(0.24)
0.48
-0.97
0.76
(0.34)
(0.01)
(0.80)

1st–6th
month
-0.97
(0.17)
1.00
(0.04)
-0.37
(0.76)

Table A2 Correlations between the L*, a*, and b* color parameters (colorimetry) vs
melanin, oxyhemoglobin (HbO2), and deoxyhemoglobin (Hb) (DRS) measured on acanthosis
nigricans neck lesions (see Chapter 8)
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Variable

N

Mean

Std Dev

P-value

L*
L*
L*
L*

1st month
2nd month
3rd month
4th month

8
8
8
8

-27.56
-26.83
-27.65
-29.48

7.86
7.63
7.56
7.77

<0.001
<0.001
<0.001
<0.001

a*
a*
a*
a*

1st month
2nd month
3rd month
4th month

8
8
8
8

-29.26
-19.49
-17.84
-16.31

15.16
25.88
27.74
30.60

<0.001
0.071
0.112
0.176

b*
b*
b*
b*

1st month
2nd month
3rd month
4th month

8
8
8
8

-47.85
-42.26
-42.17
-43.92

12.98
17.24
18.46
18.53

<0.001
<0.001
<0.001
<0.001

6
8
8
8

33.68
27.50
30.11
31.05

10.45
10.37
14.56
12.98

<0.001
<0.001
<0.001
<0.001

6
8
8
8

64.29
10.92
-3.43
10.10

114.45
32.92
73.03
61.29

0.227
0.380
0.898
0.655

6
8
8
8

-32.08
-44.81
-32.02
-44.91

27.05
26.06
25.87
35.59

0.034
0.002
0.010
0.009

Melanin
Melanin
Melanin
Melanin

1st month
2nd month
3rd month
4th month

Oxyhemoglobin
Oxyhemoglobin
Oxyhemoglobin
Oxyhemoglobin

1st month
2nd month
3rd month
4th month

Deoxyhemoglobin
Deoxyhemoglobin
Deoxyhemoglobin
Deoxyhemoglobin

1st month
2nd month
3rd month
4th month

Table A3 Percent difference in measured parameters between lesion skin and normal skin144
in the AN study (see Chapter 8)
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APPPENDIX B
STEP BY STEP INSTRUCTIONS FOR DATA PROCESSING
All the Raman spectral data obtained from Renishaw Raman spectrometer and JobinYvon Horiba Triax550 Raman spectrometer system are in .txt format.

Denoising and Normalizing
1. Make a folder, say “Data”, copy all the .txt files to the “Data” folder together with the
MatLab “adaptminmax” program.
2. Create a text file, "filelist.txt" containing all the names of the Raman spectral data
files.
a. Copy the “Data” folder to the desktop
b. Open the “command prompt” window
c. Enter "cd desktop"
d. Enter "cd Data " (now you are in the "Data" folder)
e. Enter "dir /b >filelist.txt", make sure you open the "filelist.txt" and delete the
name filelist.txt, keep only the names of the relevant files)
3. Run the “adaptminmax” program, enter "y" to see the graphs while processing.

Creating Mean Raman Spectra
1. Make a folder on the desktop, say “Mean”, and copy all the relevant .txt files to the
“Mean” folder together with the matlab “gulaygraph2” program.
2. Create a text file, “N-filelist.txt”
a. Repeat step 2, from (b) to (d) of “De-noising and Normalizing”
b. Now enter “dir /b >N-filelist.txt”.
delete the name “N-filelist.txt”
3. Run the “gulaygraph2” program.

Similarly, open the "N-filelist.txt" and
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Creating a one txt file with all the Raman Data
1. Make a folder on the desktop, say “All-Data”, and copy all the .txt files to the “AllData” folder together with the MatLab “combinespectra81706” program.
2. Create a text file, “filelist.txt”
a. Repeat step 2 of “De-noising and Normalizing”
b. Now enter “dir /b >filelist.txt”. Similarly, open the "filelist.txt" and delete the
name “filelist.txt”
3. Run the “combinespectra81706” program.
4. This will create a .txt file “allspectra.txt” with variables in columns.

PCA using SPSS
1. Open “SPSS” software
2. Click “file”, enter “read a text”
3. Change the variable names of V1 - V601 to VV600, VV602,…..VV1800
4. Go to “View variable” mode and insert three variables in the first raw.
5. Change the first variable to “string”, change the name to “Spectra”
6. Change name of the 2nd variable to “Diagnosis” and the 3rd to “Groups”
7. Click

“Value”

and

create

group

names

and

numbers,

say

1-Normal,

2-

Neuroblastoma, and 3-Ganglioneuroma
8. Go to the Data mode and copy paste the name list to the “Spectra” column
9. Now, enter value 1-3 to the relevant data cases.
10. Click “Analyze/Dimension Reduction/Factor”, select all the variables and bring those
variables to the window named variables. Now, select “extraction” as shown by the
following window.
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11. Select “Covariance matrix” and press “Continue”.

Then click “Scores” and select

“Save as variables” and press “Continue”. Now press “OK”. Then, one can see the
principal scores at the end of the variables.

DFA using SPSS
1. Click “Analyze/Classify/Discriminant”, then the following window will appear.

2. Bring the principal components from the left window to the “Independents”.

Also

bring variable “Group” to the “Grouping Variables”, then define the range from 1-3.
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Now, select “Statistics”, and select “Fisher’s” under “Functions Coefficients” and
press “Continue”.
3. Click “Classify”, and select options of “Case wise Results, Summary Table and Leaveone-out Classification” under “Display”, and “Combined-groups” under “Plots” and
press “Continue”.
4. Click “Save” and select the option of “Discriminant Scores” and press “Continue”.
Finally press “OK”. Then, the software will generate the appropriate tables and plots.

External Validation
1. Once you choose which patient data to feed as test data, delete the values of the
columns “Diagnosis” and “group” in those data cases before you do the DFA analysis.
2. Perform the DFA as explained above.
3. The results of the selected ungrouped data cases appear in the classification table as
“ungrouped cases”
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Cancer and diabetes are common chronic diseases in today’s world causing
numerous deaths in adults as well as children.

Most common types of cancers in adults

include prostate, lung, breast, colorectal and head and neck squamous cell carcinoma, while
among children; leukemia, and brain and central nervous system cancers are quite
common.

In each of these cases, early detection of the cancer or disease dramatically

increases the chances of successful treatment.

In recent years, there has been much

interest in using Raman spectroscopy and diffuse reflectance spectroscopy as analytical
optical spectroscopic methods for early diagnosis of diseases. Raman spectroscopy can be
used to measure changes in the bio-molecular composition of a tissue specimen, and diffuse
reflectance spectroscopy can measure chromophores of the skin. In this research, archived
(formalin-fixed paraffin processed) tissues of head and neck squamous cell carcinoma,
prostate, and pediatric tumors have been investigated using Raman spectroscopy. We have
utilized statistical methods such as principal component analysis (PCA) and discriminant
function analysis (DFA) to analyze the spectral output and distinguish between normal and
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cancerous tissues.

The results show cancerous tissues can be successfully distinguished

from normal tissues in three cancer types in ex vivo. However, due to loss of biochemical in
the tissue processing (paraffinizing and deparaffinizing procedure), the prediction ability of
the archived tissues are less compared to frozen tissues as observed in the pediatric tumor
investigation.
We also investigated the diagnostic capability of diffuse reflectance spectroscopy and
colorimetry on a skin disease, acanthosis nigricans in vivo.

The aim is to quantify and

characterize the skin color change associated with acanthosis nigricans skin disease in
insulin-resistant obese individuals.

We observe both the instruments can be utilized to

detect acanthosis nigricans with more than 87% sensitivity and 94% specificity when
combined with advanced chemometric methods.
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